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ABSTRACT 
Myelin fonnation is an evolutionarily late acquisition that contributes to fast 
conduction in vertebrate axons. Continuous bidirectional signaling is required for the 
acquisition and maintenance of the mature nerve fiber phenotype. Myelin Basic Prote in 
(MBP) is a representative structural component of compact myelin that is co-ordinately 
regulated with other myelin protein genes, primarily at the transcriptional level. In an 
effort to define the regulatory network controlling MBP expression, 1 located and 
functionally characterized conserved regulatory sequences in 5' non-coding sequence. 
First, 1 identified four widely-spaced segments of preferential conservation in 
orthologous human-mouse genomic sequences (tenned modules 1-4) that range from 0.1 
to 0.4 kb. In order to compare qualitative and quantitative regulatory programs mediated 
by modular and inter-modular sequences, a novel in vivo transgenesis system was 
adopted and validated. Targeted insertions of single-copy reporter constructs at a 
predetennined location within the hprt locus allowed for direct inter-construct regulatory 
pro gram comparisons. The proximal modules Ml and M2 confer relatively low-Ievel 
expression in oligodendrocytes, primarily during early postnatal development. The 
upstream M3 module conf ers high-Ievel oligodendrocyte expression extending 
throughout maturity. Furthennore, constructs devoid of M3 fail to target expression to 
newly myelinating oligodendrocytes in the mature CNS. High-Ievel and continuous 
expression is conferred to myelinating or remyelinating Schwann cells by M4. M3 also 
confers expression to Schwann cells but only transiently during active myelin elaboration 
and only when isolated from surrounding MBP sequences. These observations define the 
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regulatory roles played by a complex network of conserved non-coding MBP sequences 
and lead to a combinatorial model in which specifie permutations of regulatory sequences 
are engaged differentially in various glial cell states. This experimental system also was 
shown to provide sufficient quantitative resolution to reveal the regulatory functions 
contributed by particular modular sub-domains and individual enhancer elements. M4 
regulatory activity requires simultaneous contributions from elements located in both a 
core targeting as weIl as surrounding enhancing sub-domains with SoxlO and Krox-20 
M4 binding appearing to mediate targeting and enhancer function, respectively. From 
this investigation, the complex network of elements and transcription factors that control 
expression of one important mye lin gene has begun to emerge. This knowledge should 
lead to a deeper understanding of the regulatory mechanisms controlling the overall 
myelination program and, ultimately, to novel therapeutic strategies effective III 
ameliorating the consequences of inherited or acquired demyelinating disease. 
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RÉSUMÉ 
La myéline est une acquisition récente dans l'évolution qui contribue à la 
conduction rapide de l'influx nerveux dans les axones des vertébrés. Une communication 
continue entre les neurones et les cellules gliales est nécessaire pour la formation et le 
maintien du phénotype de la fibre nerveuse mature. La Protéine Basique de la Myéline 
(MBP) est un composant structurel de la myéline compactée qui est principalement 
regulé, avec d'autre gènes de protéines de la myéline, au niveau transcriptionnel. Dans le 
but de définir le réseau de régulation controlant l'expression de la MBP, j'ai localisé et 
charactérisé la fonction de séquences régulatrices conservées durant l'évolution 
présentent dans la région 5' flanquante du gène. Dans un premier temps, j'ai identifié 
quatre segments (dénommés module 1-4) largement espacés d'une longueur variant entre 
0,1 et 0,4 kb et présentant une conservation préférentielle dans les séquences orthologues 
humaine et murine. Afin de comparer de manière qualitative et quantitative les 
programmes de régulation médiés par les modules et les séquences inter-modulaires, une 
nouvelle technique de transgénèse a été utilisée et validée. L'insertion ciblée des 
constructions dans le locus hprt à permis la comparaison directe des programmes de 
régulation. Les modules proximaux Ml et M2 confèrent une expression relativement 
faible dans les oligodendrocytes durant le développement postnatal précoce. Le module 
M3 situé plus en amont confères un haut niveau d'expression dans les oligodendrocytes 
tout au long du développement. De plus, les constructions ne contenant pas M3 ne 
s'expriment pas dans les oligodendrocytes formant de la myèline dans le système nerveux 
mature. Une expression importante et continue dans les cellules de Schwann au cours de 
la myélination ou de la remyélination est donnée par M4. Une expression transitoire est 
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dirigée dans les cellules de Schwann durant la myélination par M3, dans ce cas 
uniquement lorsque ce module est isolé des séquences flanquantes du gène de la MBP. 
Ces observations définissent les rôles régulateurs joué par un ensemble de séquences non-
codantes conservées du gène de la MBP menant à un modèle combinatoire dans lequel 
des combinaisons spécifiques de séquences régulatrices sont engagées dans les différents 
types cellulaires et aux différents stades de differentiation. Ce systême experimental a 
une résolution quantitative suffisante pour révéler les fonctions régulatrices apportées par 
des sous-domaines et des éléments individuels des enhancer. La régulation donnée par 
M4 requière les contributions simultanées d'éléments localisés au coeur de l'enhancer 
ainsi que d'éléments dans les séquences flanquantes. La liaison des facteurs de 
transcription SoxlO et Krox-20 à M4 médie, respectivement, le ciblage et l'amplification 
de l'expression. De cette étude, le réseau complexes des éléments et des facteurs de 
transcription controlant l'expression d'un gène important de la myéline apparaît. Cette 
connaissance devrait permettre une compréhension plus profonde des méchanismes 
contrôlant la myélination et la découverte de nouvelles stratégies thérapeutique visant à 
améliorer les conséquences des maladies de la myéline. 
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CHAPTERI 
GENERAL INTRODUCTION 
PREFACE 
Central and peripheral nervous system myelinogenesis represent fundamental 
adaptations of vertebrates and are hallmarks of oligodendrocyte and Schwann cell 
maturation, respectively. Multilayered lipoprotein myelin sheaths serve to insulate axons, 
facilitate saltatory conduction, and contribute to neuronal function. The mechanisms 
undedying myelinating glial cell differentiation and maturation from multipotent 
precursors have become increasingly well-characterized, with essential transcriptional 
regulators identified in recent years. In marked contrast, the signaling pathways 
governing the tightly controlled processes of myelin assembly and long-term stability 
remain poody understood. 
The pnmary objective of this thesis is to gam further insight into the 
transcriptional regulation of a representative mye lin protein gene, Myelin Basic Protein 
(MBP) , during development, maturity, and following injury. This chapter provides a 
review of the background rationale and details the objectives for the investigations 
presented in subsequent chapters. 
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As this chapter is being published in a book on multiple sclerosis, it includes the 
general findings and conclusions of my thesis research (which are presented in greater 
detail in subsequent chapters), in addition to the objectives and rationale. 
THE MYELIN BASIC PROTEIN GENE: A PROTOTYPE FOR 
COMBINATORIAL MAMMALIAN TRANSCRIPTIONAL REGULATION 
Hooman F. Farhadi and Alan C. Peterson 
In Press: Advances in Neurology: Multiple Sclerosis and Demyelinating Diseases 
SUMMARY 
In this chapter, we reVlew recent investigations that expose the strategies 
evolution adopted to control the complex gene expression programs realized by the 
"myelin gene family". We focus on the mechanism controlling transcriptional regulation 
of one family member, the myelin basic prote in (MBP) gene. Regulatory activity at the 
MBP locus arises from widely dispersed enhancer modules consisting of short non-
co ding sequences that are highly conserved throughout mammals and in most non-
mammalian vertebrates. Each confers a discrete regulatory sub-program to the overall 
MBP expression phenotype with expression in oligodendrocytes conferred through 
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multiple proximal modules and the proximal promoter while Schwann cells rely upon a 
far upstream module. Beyond their well-characterized autonomous functions, such 
modules engage in combinatorial relationships to refine both cell-type specificity and 
quantitative expression phenotypes. Of relevance to myelin cell biology, this 
combinatorial organization underlies an unsuspected maturation pro gram in which the 
transcription factor repertoire regulating MBP expression evolves with age. Thus, the 
combination and/or relative activity of transcription factors engaged during primary 
myelin elaboration is not present in mature myelin maintaining oligodendrocytes or, most 
remarkably, in remyelinating oligodendrocytes in mature animaIs. Should this 
circumstance also exist in humans, fundamental characteristics of the cells targeted in 
adult MS lesions, as well as those attempting myelin repair, are specific to the mature 
nervous system. 
INTERDEPENDENCE OF AXONS AND THEIR MYE LINA TING GLIA 
Myelin formation represents a relatively recent evolutionary adaptation of 
vertebrates. The electrical insulation afforded by compacted mye lin membranes in the 
central and peripheral nervous systems allows for rapid and energy efficient conduction 
over long distances while respecting necessary size constraints. Within fast conducting 
myelinated nerve fibers, the morphological and functional phenotypes of axons and their 
supporting glia develop and are maintained through continuous bi-directional signaling 
throughout development and in the adult. 
Significant differences exist in the way myelinating glia interact with axons in the 
central and peripheral nervous systems. Whereas a single oligodendrocyte may myelinate 
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scores of different axons, a myelinating Schwann cell associates with a single axon. The 
correlation between the caliber of the innervating axon and myelination is much tighter in 
the PNS than in the CNS (Aguayo et al., 1977; Peters et al., 1991). When Schwann cells 
are isolated from the innervating axon, either through denervation in vivo or isolation in 
culture, they revert to a non-myelinating phenotype and down-regulate the genes for the 
major myelin associated proteins to low basallevels (LeBlanc and Poduslo, 1990; Lemke 
and Chao, 1988; Trapp et al., 1988). Isolated oligodendrocytes, on the other hand, 
continue to extend their processes and induce and maintain ~30% of the normallevel of 
expression of myelin genes (Abney et al., 1981; Bradel and Prince, 1983; Zeller et al., 
1985). 
Despite these differences, mye lin formation and maintenance is the final step in 
the maturation of both oligodendrocytes and Schwann cells, and involves a complex and 
tightly regulated process that is supported by an intimate axon-glial physical inter-
relationship. The synthesis and assembly of myelin specific components in all terminally 
differentiating glial cells must be precisely orchestrated to give rise to myelin. On the one 
hand, myelination leads to local changes in the cytoarchitecture of the axon as well as to 
more systemic changes in the biology of myelinated neurons including phosphorylation 
status and slow anterograde axonal transport (Aguayo et al., 1979; Brady et al., 1999; de 
Waegh et al., 1992; Kirkpatrick et al., 2001). AIso, the clustering of sodium and 
potassium channels at the node and the juxtaparanode, respectively, is dependent on 
oligodendrocytes (Baba et al., 1999; Kaplan et al., 1997; Rasband et al., 1999) and 
Schwann cells (Arroyo et al., 1999; Joe and Angelides, 1992). 
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Conversely, axons also appear to control multiple features of their myelin sheaths 
(Michailov et al., 2004; Notterpek and Rome, 1994). Part of the control that axons exert 
over glial cells appears to be mediated through the coordinated regulation of specifie 
developmentally regulated genes encoding myelin specifie proteins. Early in vitro 
experiments showed that, in addition to neurons being mitogenic for oligodendrocytes 
and Schwann cells (DeVries et al., 1982; Wood and Bunge, 1986), isolation of glial cells 
from axons results in a downregulation of myelin specifie genes with only partial 
restoration of expression in co-cultures (David et al., 1984; Macklin et al., 1986). In vivo 
differentiation of oligodendrocytes in the optic nerve is c10sely related to axonal integrity 
(Kidd et al., 1990; McPhilemy et al., 1990; Valat et al., 1988). Furthermore, modulation 
of mye lin prote in gene expression by axons is also observed under various experimental 
conditions, such as following nerve transection (LeBlanc and Poduslo, 1990; McPhilemy 
et al., 1990; Scherer et al., 1992). 
It seems likely that both soluble and cell-mediated signaIs from adjacent axons are 
integrated into the developmental profile of oligodendrocyte precursors resulting in cell 
differentiation, up-regulation of myelin gene expression, and formation of mature myelin. 
For instance, oligodendrocyte maturation and survival is influenced by neuregulins 
expressed on axons (Fernandez et al., 2000; Vartanian et al., 1999). Neuregulin exposure 
induces morphologie al changes in cultured oligodendrocytes (Canoll et al., 1999). In the 
absence of the neuregulin receptor ErbB2, while many oligodendrocyte precursors 
develop, few of these cells mature and those that do fail to interact with axons and do not 
produce myelin (Kim et al., 2003; Park et al., 2001). In the PNS, axonally derived 
neuregulin promotes differentiation along a glial path (Britsch et al., 1998; Sandrock et 
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al., 1997) and has recently been shown to function as a key regulator of myelin sheath 
thickness in vivo (Michailov et al., 2004). Moreover, NGF has recently been shown to 
mediate potent, but inverse effects on myelination by Schwann cells and 
oligodendrocytes, likely through changes in the axonal signaIs that control myelination 
(Chan et al., 2004). 
Other candidates for axonally derived soluble factors include fibroblast growth 
factors (Qian et al., 1997), thyroid hormone (Barres et al., 1994), and adenosine (Stevens 
et al., 2002). In particular, adenosine released in an activity-dependent manner by dorsal 
root ganglia axons promotes differentiation of oligodendrocyte precursors into MBP-
expressing cells containing multiple processes and forming compact myelin sheaths. 
Myelination also appears to be regulated by electrical activity alone (Demerens et al., 
1996; Stevens and Fields, 2000). Treatment of CNS expIant cultures with tetrodotoxin 
results in significantly fewer mye lin intemodes transiently while treatment with u-
scorpion toxin (a selective sodium channel activator) results in a significant increase. 
Finally, axonal cell surface molecules such as LI, MAG, NCAM, and N-cadherin may 
also regulate formation of the myelin sheath (Martini, 1994). 
POTENTIAL MBP TRANSCRIPTIONAL REGULATORS 
Glial cells and their progenitors have historically been characterized primarily by 
their morphologies and expression of a small number of lineage and myelin markers. 
However, exciting insight into the regulatory machinery and the signaling pathways that 
control their major expression features is rapidly emerging (Wegner, 2001). Despite the 
fact that only few such factors are well characterized, they are providing progressively 
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greater insight into the requirements for lineage specification, progression and terminal 
differentiation (Arnett et al., 2004; Stolt et al., 2002). Notably, as the number of factors 
implicated in myelin cell biology grows, insights into unanticipated spatial and temporal 
oligodendrocyte heterogeneity have emerged; where both the Nkx6 transcription factor 
and the Sonic hedgehog signaling system were thought to be essential for the origin of 
the oligodendrocyte lineage, recent investigations demonstrate that oligodendrocytes 
appearing later in the dorsal spinal cord share no such requirements (Cai et al., 2005; 
Vallstedt et al., 2005). 
MYE LIN PROTEIN GENE PROMOTER ANAL YSIS 
Developing a comprehensive catalog of the transcription factors controlling 
oligodendrocyte gene expression in aIl developmental states would provide a foundation 
from which novel interventions will likely emerge. While many difficulties are yet to be 
addressed before we develop such understanding, genome wide strategies capable of 
evaluating the transcription factor repertoire are currently under development and limited 
application. Importantly, transcriptional regulation in complex organisms is not a simple 
matter of tuming a gene on at the right time in the right cell type. Rather, the basic 
mechanism emerging involves scores of factorlDNA element interactions that may be 
engaged to effect positive, negative, or neutral consequences on gene output. Further, not 
aIl relevant interactions are likely to occur in the cells positively regulating the locus; 
active silencing in inappropriate cell types or at specific stages of lineage progression 
also may be required. Thus, to complement the insights expected from genome-wide 
molecular approaches, it is essential that multiple model loci are sufficiently weIl 
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characterized to expose the actual structure/function relationships within their cis-linked 
regulatory sequences. It is our goal to introduce a myelin gene into this model locus 
category. 
The promoters of myelin protein genes have been analyzed us mg in vitro 
preparations and for several, regulatory sequences which identify relevant transcription 
factors regulating myelin formation have emerged (Brown and Lemke, 1997; Clark et al., 
2002; He et al., 1991; Miskimins et al., 2002; Monuki et al., 1993; Monuki et al., 1990; 
Monuki et al., 1989; Peirano and Wegner, 2000; Shy et al., 1996; Wei et al., 2003, 2005). 
However, since no in vitro model fully recapitulates the myelinating glial phenotype, and 
given the apparent importance of bi-directional signaling with intact axons, reliable 
dissection of control mechanisms with in vitro techniques has proved difficult. 
Ideally, direct insight into the complex in vivo axon-glia relationships should be 
achievable through mouse transgenic technology. Following this strategy, several 
laboratories have investigated the regulatory capacity of sequences flanking 
representative mye lin prote in gene members. Transgenic mice have been derived bearing 
reporter constructs regulated by various lengths of 5' flanking sequence from the 
proteolipid protein, MBP, protein zero, peripheral myelin protein 22, and 2', 3' cyclic-
nucleotide 3 '-phosphodiesterase genes. Targeting to oligodendrocytes and/or Schwann 
cells has been demonstrated with varying efficiency (Foran and Peterson, 1992; Gow et 
al., 1992; Gravel et al., 1998; Maier et al., 2002; Messing et al., 1992; Wight et al., 1993; 
Wrabetz et al., 1998). 
Unfortunately, until recently, reliable and efficient identification of cis-regulatory 
sequences using classic transgenic methodologies has been seriously limited. Variability 
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in transcriptional efficiency attributable to unpredictable transgene copy numbers and 
local chromatin effects at the site of integration combined to confound the interpretation 
of regulatory phenotypes and have precluded fine structure analysis. To resolve these 
issues, and to locate and characterize the elements regulating in vivo transcription of the 
MBP locus, we employed a recently described controlled transgenesis strategy wherein 
single-copy construct insertion at the hypoxanthine-guanine phosphoribosyltransferase 
(hprt) locus allows for high resolution interconstruct qualitative and quantitative 
comparisons (Bronson et al., 1996; Cvetkovic et al., 2000; Vivian et al., 1999) (see 
Figure 1). 
Several features of MBP and its regulatory phenotype make it an ideal candidate 
gene for elucidating mechanisms underlying axon-glia interactions. As a major 
component of the major dense line, MBP plays an essential and rate-limiting role in CNS 
mye lin formation (Kirschner and Ganser, 1980; Privat et al., 1979). Also, it is a well-
characterized experimental auto-antigen with potential roles at multiple levels in immune 
mediated mechanisms of myelin destruction (Lutton et al., 2004). It is present in both 
CNS and PNS myelin where it accounts for 5-15% and 30-40% of myelin protein 
content, respectively (Greenfield et al., 1973; Hahn et al., 1987; Milek et al., 1981). MBP 
appears to be differentially regulated throughout oligodendrocyte lineage progression, 
achieving highest levels in terminally differentiated myelinating cells with modestly 
reduced levels maintained throughout maturity into senescence. Expression also appears 
to be tightly regulated under numerous experimental conditions involving demyelination 
and remyelination (LeBlanc and Poduslo, 1990; Woodruff and Franklin, 1999). Both 
oligodendrocytes and Schwann cells regulate the appearance of MBP primarily at the 
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transcriptional level (Wiktorowicz and Roach, 1991) with such expression coordinated in 
time and place with other myelin-related genes in both cell types in response to axonal 
cues (Gordon et aL, 1990; Notterpek et aL, 1999). Finally, MBP is a potential 
susceptibility gene for MS in the context of a small Finnish population (Pihlaja et aL, 
2003), raising the intriguing possibility that dysregulated MBP expression may be a 
component in MS onset. 
Investigations using classic transgenic preparations have shown that the proximal 
MBP promo ter targets developmentally appropriate temporal expression to 
oligodendrocytes but not Schwann cells (Foran and Peterson, 1992; Goujet-Zalc et al., 
1993; Gow et al., 1992) while 5' flanking sequences extending to approximately -6 kb or 
-9 kb yield more robust expression (Farhadi et aL, 2003; Forghani et aL, 2001). 
Additionally, the -9kb sequence also targets expression to developing, mature, and 
remyelinating Schwann cells. 
COMBINATORIAL CONTROL OF TRANSCRIPTION 
The regulation of gene expression in multi-cellular organisms is complex and for 
each locus, occurs through the coordinated action of multiple transcription factors acting 
on large numbers of regulatory elements. A common theme of such regulatory 
mechanisms is a combinatorial organization (Halfon et aL, 2000; Yuh et aL, 1998). A 
combinatorial strategy of transcriptional regulation allows the organism to dynamically 
control gene expression in response to a variety of environmental or developmental 
signaIs through different combinations of a limited number of transcriptional regulators. 
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The cis-regulatory system of the developmentally regulated endo16 gene of the 
sea urchin has been investigated to perhaps greater depth than any other locus and thus 
serves as a useful model (Yuh et al., 1998, 2001). Its major regulatory sequence is 
contained within approximately 2300 bp and consists of several clusters of target sites 
that operate as separable modular regulatory units that execute distinct qualitative or 
quantitative functions. Through a detailed spatiotemporal analysis of endoderm reporter 
expression in numerous lines bearing different permutations of normal or mutated 
enhancer elements, Davidson and colleagues successfully developed a quantitative 
computational model that appropriately reflects the integrated output of defined 
regulatory sequences. Of significance, most endo16 elements confer only small 
quantitative effects that, in aggregate, determine the integrated expression programming. 
Although the analysis of endo16 greatly enhanced our ability to contemplate the 
fine structure of the regulatory networks functioning in vertebrate and mammalian 
systems, elucidating the transcriptional regulatory network in such higher order 
organisms represents a much more daunting task; each experimental approach, either 
computational or functional, provides only partial answers (Fickett and Hatzigeorgiou, 
1997; Fickett and Wasserman, 2000; Werner, 1999). Currently, a synthesis of multiple 
approaches is employed that includes genomic sequence annotation, cross-species 
sequence comparisons, functional analysis of reporter constructs and abstract model 
building. 
Patterns of gene regulation and the corresponding regulatory controls are often 
conserved across species and cross-species sequence comparison has emerged as a 
powerful means to reveal functionally relevant regulatory sequences. Relying on the 
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principle that selective pressure over functional regulatory sequences causes them to 
evolve slower than sUITounding unselected sequences, these so called phylogenetic 
footprints are expected to confer various regulatory functions (Cawley et al., 2004; Saluja 
and Kohane, 2003). In this regard, the mouse genome has received considerable attention 
given that its genomic sequences are now easily accessible and that there is a wealth of 
similarity to many human-relevant biological and disease processes (including 
myelination and inherited and acquired myelin diseases). Using recently developed 
computational methods and evolving genomic databases from an increasing number of 
species, interspecies sequence comparisons are performed in an efficient and 
comprehensive manner (Dermitzakis et al., 2002; Frazer et al., 2003; Schwartz et al., 
2000; Wasserman et al., 2000; Waters ton et al., 2002; Wingender et al., 2001). While the 
general usefulness of human-mouse sequence comparisons as a systematic guide to 
functionally relevant regulatory sequences remains untested, evolutionarily conserved 
sequences (in the range of hundreds of base pairs) are associated with many loci and to 
date, many such conserved non-coding sequences have been assigned regulatory 
functions (Farhadi et al., 2003; Gottgens et al., 2000; Loots et al., 2000; Oeltjen et al., 
1997; Pennacchio et al., 2001; Tumpel et al., 2002). 
EVIDENCE FOR COMBINATORIAL CONTROL OF MBP TRANSCRIPTION 
The MBP transcriptional unit maps to chromosome 18 in both mouse and human 
where it is distributed over a length of approximately 32 kb and 45 kb, respectively. 
Interestingly, it is contained within a much larger transcriptional unit (spanning 105 kb in 
mouse and 179 kb in human) that includes the gene Golli (gene expressed in the 
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oligodendrocyte lineage) at its 5' end. The first three MBP exons and the proximal MBP 
promoter contribute to translated Golli exons (Campagnoni et al., 1993; Pribyl et al., 
1993). While non-coding domains have an average level of human-mouse conservation 
approximating 30-40%, with an upper limit near 80% (Jareborg et al., 1999), the MBP 
genomic domain fortuitously appears to have undergone evolutionary change at a 
comparatively greater tempo revealing an overall level of conservation at the lower end 
of this scale. 
Given this circumstance, sequences conserved functionally should be clearly 
highlighted as conserved regulatory regions between highly substituted non-functional 
adjacent sequence. Therefore, in our initial attempts to highlight MBP regulatory 
sequences through phylogenetic footprints, we used thresholds of identity of 75% over a 
pre-specified minimum length (100 bp) to define sequence conservation. We scanned 25 
kb of human and 12 kb of mouse 5' flanking orthologous sequences and identified four 
islands ofmarked sequence conservation (termed modules 1-4). All modules were ligated 
into reporter genes that were introduced, in single copy, 5' of the hprt locus and 
investigated for cis-regulatory activity in subsequent lines of transgenic mice (Farhadi et 
al., 2003) (also see Figure 1). 
A diverse range of in vivo expression phenotypes, including different cell 
specificities, developmental programming and expression levels was observed (Figures 2 
and 3). From these observations, it became evident that the MBP regulatory mechanism 
controls transcription through a combination of seemingly autonomous modular 
contributions that are overlain with functions derived from integrated arrangements 
(Figure 4). 
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Thus, multiple sub-programs were discemed and amongst these, perhaps the most 
striking is the requirement of module 3 for high-Ievel expression in mature mice. This 
observation requires that the MBP relevant transcription factor repertoire of mature 
oligodendrocytes differs from that of the less mature oligodendrocytes in pre-weaning 
mice, either as a response to an intrinsic developmental pro gram or as a change 
secondary to extrinsic differences in the environment provided in the juvenile versus the 
mature brain. In either case, this observation defines a novel level of temporal 
oligodendrocyte heterogeneity. 
To explore the potential ongm of such age-associated heterogeneity, we 
investigated the regulatory phenotype of oligodendrocytes remyelinating in the mature 
nervous system. Transgene expression was evaluated in mice bearing constructs 
containing only modules 1 and 2 (Farhadi et al., 2003). In response to intrathecal 
injection of saporin conjugated to the beta subunit of cholera toxin, oligodendrocytes 
mount a significant remyelination response (Jasmin et al., 2000) but, surprisingly, we 
obtained no evidence indicative of transgene expression in newly myelinating 
oligodendrocytes bearing these constructs devoid of module 3. In contrast, observations 
from randomly targeted MBP-LacZ transgenic lines regulated by 5' flanking sequences 
containing module 3, reveal that adult newly myelinating oligodendrocytes do express 
their transgene reporter coincident with new myelin deposition (Finsen and Peterson, 
2001). 
From these observations, it is apparent that at least part of the regulatory 
mechanism used to control MBP transcription during primary development is not in 
service during myelin repair in the mature CNS. In the context of MS lesions, while sorne 
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controversy exists regarding the density of the progenitor population in reglOns of 
demyelination (Lassmann et al., 1997; Woiswijk, 1998b; Zhang et al., 1999), it IS 
nevertheless c1ear that such cells possess atypical myelination capabilities. In this regard, 
oligodendrocyte precursors have c1early been identified lying directly within chronic 
plaques of MS patients (Woiswijk, 1998a). Why these cells do not aggressively repair the 
demyelinated lesions, and why those oligodendrocytes that eventually do enter an active 
myelination program slowly elaborate only thin mye lin, remain largely unanswered 
questions. As the differences observed in the MBP transcriptional mechanism operating 
in primary development and in oligodendrocytes remyelinating in the mature brain may 
change expression of an essential myelin constituent, they may contribute to the 
protracted and incomplete process of remyelination often observed in the diseased or 
injured adult CNS. 
To identify the regulatory sequences and factors that confer the module 3 
expression phenotype, and in an effort to characterize the regulatory cascade functioning 
during adult myelin maintenance and regeneration, an intense analysis of module 3 
elements and their relationship to expression in mature and remyelinating 
oligodendrocytes is currently underway (Dionne et al., 2005). In the initial round of 
investigations, we focused on Nkx6.2/Gtx, an oligodendrocyte-specific homeodomain 
prote in known to avidly bind TAAT-containing consensus sites (Awatramani et al., 2000; 
Awatramani et al., 1997) and that is coordinately expressed with several myelin-specific 
mRNAs in multiple cell states (Sim et al., 2000). While a module 3 construct bearing 
mutations in two of three Nkx6.2/Gtx consensus sites retains continuous oligodendrocyte 
targeting activity, quantitative analysis revealed a significant decrease in transcriptional 
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efficiency (Farhadi et al., 2003). Thus, this transcription factor, or related homeodomain 
proteins, appears to function within a complex framework finely modifying module 3 
output. 
Taken together, observations summarized III this chapter demonstrate that 
different combinations of regulatory sequences control MBP expreSSIOn during 
development, mye lin maintenance and remyelination. Though the picture is far from 
complete and notable exceptions are emerging, vast numbers of positive cis-regulatory 
elements account for the major spatiotemporal features of MBP expression. The specific 
temporal, spatial, and quantitative output from the MBP gene is determined by the 
particular combination of evolutionarily conserved cis-regulatory binding sites that are 
engaging transcription factors. To arrive at a more complete picture of this complex cis-
regulatory circuitry, the fine structure of individual enhancers as weIl as more in-depth 
analysis of modular interactions and negative regulatory activities will be required. 
Fortunately, the HPRT based controlled strategy of transgenesis is sufficiently robust to 
reveal the role played by individual elements and, consequently, is ideally suited to 
support such investigations (Denarier et aL). Additionally, initial in vitro experiments, 
including transfection analysis, DNase 1 footprinting, and electrophoretic mobility shi ft 
assays, are underway by our group and others (Taveggia et al., 2004) using the conserved 
modular sequences. 
CONCLUSION 
Although nothing of therapeutic relevance for patients with MS has emerged so 
far from past and CUITent investments in basic gene regulation mechanisms, this endeavor 
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appears poised to yield insights with practical consequences. The convergence of recent 
discoveries in genome organization, along with the unexpected developments of 
strategies to modulate gene output (small interfering RNAs, chimeroplasty, exon 
skipping, etc.) suggest that opportunities to control the stability and/or responsiveness of 
myelin forming cells, in c1inically meaningful ways, is within reach. Beyond this 
emerging potential, greater understanding of the mechanisms regulating gene expression 
is, of itself, offering a disease relevant window into the myelination pro gram in effect at 
different stages of oligodendrocyte maturation. By achieving insight into the molecular 
mechanisms regulating myelin formation and repair, we anticipate that novel 
opportunities to stabilize mye1in in the diseased CNS and to promote repair following 
demye1inating episodes will become evident. 
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Figure 1: Diagram depicting deletion in the hprt locus where constructs are docked and 
the genotype of the transgene locus following homologous recombination of the construct 
bearing targeting vector. RAT selection following transfection with appropriate targeting 
vectors allows survival only of clones in which homologous recombination has 
simultaneously restored deleted RPR T expression and inserted a single copy of the 
experimental construct, at a known site and orientation 5' of the hprt locus (Bronson et 
al., 1996). PHF6 indicates the next 5' locus. 
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Figure 2: Phylogenetic footprints revealed by comparison of 5' MBP sequence from 
mouse and human. The human sequence is displayed on the X-axis while the % identity, 
measured in a 100 bp window, is indicated on the y axis. In the proximal promoter 
sequence, extensive and high levels of conservation are encountered that in this analysis, 
define two separable modules. More upstream is module 3 and further upstream yet is 
module 4. Whole mount histochemical preparations displayed below show that module 4 
containing constructs express in Schwann cells, and not oligodendrocytes, while 
constructs bearing the more 3' modules are expressed in oligodendrocytes only. In both 
constructs, lacZ is the reporter gene. In the Mod3/2/1 construct, MBP 5' flanking 
sequence was ligated directly to lacZ while in the module 4 construct, a minimal 300 bp 
heat shock protein promoter was introduced between module 4 and the lacZ reporter. 
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Figure 3: Sciatic nerve and cervical spinal cord samples were obtained from transgenic 
mice containing constructs bearing different combinations of MBP regulatory modules. 
Samples were recovered at postnatal day 18 when myelin elaboration, MBP and construct 
expression are at, or near, maximal levels. As constructs were docked in an X 
chromosome site, for one potentially active construct copy to be available in aIl ceIls, 
analyzed mice were either transgene bearing males or homozygous females. Mice 
analyzed in this study were derived from intercrosses between C57Bl/6, 129PAS and 
1290LA inbred strains and therefore, had variable genetic backgrounds. Truncated 
modules are indicated by *. Bars represent means and error bars SD. 
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Figure 4. The 5' flanking region of the mouse MBP locus along with its 4 regions of high 
inter-species conservation (colored rectangles) is shown. The positive relationships 
defined so far that can drive expression in developing, mature and remyelinating cells are 
represented as solid arrows. Those above the flanking sequence positively regulate 
expression in oligodendrocytes while solid arrows below positively regulate expression in 
Schwann cells. Dotted lines represent the general location of various negative regulatory 
activities. 
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CHAPTER2 
PREFACE 
This chapter presents the main bu1k of primary data contributed by this 
thesis. It a1so provides the scientific basis for the ongoing use of high-reso1ution in 
vivo controlled transgenesis strategies to e1ucidate the transcriptiona1 mechanisms 
and machinery regu1ating MBP expression in deve10pment and maturity. A 
comp1ex network of evo1utionari1y conserved regu1atory motifs is observed to 
differentially regu1ate MBP expression in myelinating glia during various 
differentiation states as seen during deve10pment, maturity, or following injury. As 
such, an investigative too1 is va1idated for the identification of the relevant 
transcription factors and cellular signa1ing engaged in such diverse glial states. 
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ABSTRACT 
Myelin basic protein (MBP) is required for normal myelin compaction and is 
implicated in both experimental and human demyelinating diseases. In this study, as an 
initial step in defining the regulatory network controlling MBP transcription, we located 
and characterized the function of evolutionarily conserved regulatory sequences. Long-
range human-mouse sequence comparison revealed over 1 kb of conserved non-co ding 
MBP 5' flanking sequence distributed into four widely spaced modules ranging from 0.1 
to 0.4 kb. We demonstrate first that a controlled strategy of transgenesis provides an 
effective means to assign and compare qualitative and quantitative in vivo regulatory 
programs. Using this strategy, single-copy reporter constructs, designed to evaluate the 
regulatory significance of modular and inter-modular sequences, were introduced by 
homologous recombination into the mouse hprt locus. The proximal modules Ml and M2 
3 
confer comparatively low-Ievel oligodendrocyte expression primarily limited to early 
postnatal development while the upstream M3 confers high-Ievel oligodendrocyte 
expression extending throughout maturity. Further, constructs devoid of M3 fail to target 
expression to newly-myelinating oligodendrocytes in the mature CNS. Mutation of 
putative Nkx6.2/Gtx sites within M3, while not eliminating oligodendrocyte targeting, 
significantly decreases transgene expression levels. High-Ievel and continuous expression 
is conferred to myelinating or remyelinating Schwann cells by M4. In addition, when 
isolated from surrounding MBP sequences, M3 confers transient expression to Schwann 
cells elaborating myelin. These observations define the in vivo regulatory roles played by 
conserved non-coding MBP sequences and lead to a combinatorial model in which 
different regulatory modules are engaged during primary myelination, mye lin 
maintenance, and remyelination. 
INTRODUCTION 
The myelin sheath is a specialized glial membranous organelle essential for rapid 
and energy efficient action potential conduction. Perturbations of the sheath, as in 
multiple sclerosis (MS), may also lead to axonal degeneration (Bjartmar et al., 2003). The 
process of remyelination is invariably prolonged as compared to primary myelin 
deposition, and often results in thin sheaths with only partial recovery of conductive 
properties. Thus, an understanding of the mechanisms that control myelination and 
remyelination are key to the development of therapeutic strategies to treat demyelinating 
diseases. 
4 
The search for potential regulators of glial cell development and axon-glia 
signaling has led to the identification of numerous candidate transcription factors 
including the basic-helix-Ioop-helix proteins Oligl and Olig2, the homeodomain proteins 
Tst-lISCIP/Oct-6 and Nkx6.2/Gtx, the zinc finger protein Krox-20/Egr2, and the HMG-
domain protein Sox-l0 (Awatramani et al., 1997; Bermingham et al., 1996; Britsch et al., 
2001; Topilko et al., 1994; Zhou and Anderson, 2002). However, the upstream glial 
signaling pathways and the full complement of interacting transcription factors remain to 
be elucidated. 
Mouse transgenesis provides an ideal system to examine regulatory phenotypes 
under normal and experimental conditions. Using this approach, various lengths of 5' 
flanking sequence from the proteolipid protein, MBP, protein zero, peripheral myelin 
protein 22, and 2 ',3' cyclic-nucleotide 3 '-phosphodiesterase genes have been 
demonstrated to target reporter expression to oligodendrocytes or Schwann cells (Foran 
and Peterson, 1992; Gow et al., 1992; Gravel et al., 1998; Maier et al., 2002; Messing et 
al., 1992; Wight et al., 1993; Wrabetz et al., 1998). However, identifying cis-regulatory 
sequences by this method has been limited by variability associated with copy number 
and position effects at random transgene insertion loci. The recent description of a 
controlled transgenesis strategy permitting single-copy construct insertion by 
homologous recombination at the hprt locus resolves these issues allowing for higher 
resolution inter-construct comparisons (Bronson et al., 1996; Cvetkovic et al., 2000; 
Vivi an et al., 1999). 
Regulatory sequences are thought to constitute a small fraction of the non-coding 
portion of the mammalian genome (Waterston et al., 2002). Computational sequence 
5 
analysis and inter-species comparisons have been used to identify conserved non-coding 
sequences with potential gene regulatory properties. To date, however, evolutionarily 
conserved sequences associated with only a few loci have been assigned regulatory 
functions (Gottgens et al., 2000; Loots et al., 2000; Oeltjen et al., 1997; Pennacchio et al., 
2001). 
In this study, we combined human-mouse non-co ding sequence comparison with 
targeted transgenesis at the hprt locus to identify the in vivo cis-regulatory network 
controlling MBP, an essential constituent of central and peripheral myelin (Peterson and 
Bray, 1984; Readhead et al., 1987). We find that the regulatory programming ofMBP is 
accounted for by four widely spaced conserved sequence modules. Each module conf ers 
a distinct quantitative and spatiotemporal expression pattern defining specific regulatory 
programs for primary myelination, mye lin maintenance, and remyelination following 
in jury. Taken together, our observations highlight this combined approach as a valuable 
tool for assigning qualitative and quantitative in vivo regulatory phenotypes and provide a 
basis for modeling the cis-regulatory system controlling mye lin prote in gene expression. 
MATERIALS AND METHODS 
Isolation of human and mouse MBP clones 
Ruman MBP PAC clone 248_D_12 was isolated by screening the RPCI.l Ruman 
PAC library with chromosome 18 STS marker WI-9286, and validated with GollilMBP 
exon-specific primers. PAC DNA was prepared from 2L cell cultures in LB-Broth 
containing 30 jJg/ml of kanamycin. DNA was isolated using a midi-prep kit following 
manufacturer's instructions (Qiagen). PAC DNA was sheared using a sonicator to an 
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average of 2 Kb fragments. The ends of the fragments were repaired with Mung Bean 
Nuclease (New England Biolabs). The fragments were gel purified twice to select for 2 
kb fragments and ligated into an M13mp18 vector digested with SmaI. The reactions 
were then transformed into XL-2 competent cells (Stratagene). Individual plaques ofM13 
subclones were grown for 16 hours at 37°C in 0.5 ml of 2X YT with 10 III of log-phase 
TG-1 bacterial cells. Single strand M13 DNA for sequencing was obtained from 100 III 
of the culture supematant using magnetic beads (PerSeptive Diagnostics) following 
manufacturer's instructions. Isolation of a mouse MBP genomic lambda DashII clone 
(approximately 15 kb) was described previously (Foran and Peterson, 1992). 
Sequencing 
Sequencing of the M 13 clones was done with the Dye Primer Cycle Sequencing 
Ready Reaction Kit (Applied Biosystems). Sequencing reactions included approximately 
400 ng of M13 DNA in 1.5 III and 3 III of reaction mixture for each of the four labeled 
primers. The thermal cycling parameters were: 15 cycles at 96°C for 10 s,55°C for 5 s 
and 70°C for one min, followed by 15 cycles at 96°C for lOs and 70°C for 1 min. The 
four reactions were mixed and purified with an ethanol precipitation. Samples were 
loaded and run on an ABI 377 Sequencer according to the manufacturer's instructions 
(Applied Biosystems). A portion of the mouse sequence (-12 Kb to -3 Kb) was obtained 
by walking using specific oligonucleotide primers and analyzed on a LICOR sequencer. 
Ambiguous mouse and human sequences were verified using the DyeTerminator system 
(Applied Biosystems) with specific primers. The sequences were supplemented with 
7 
available sequences present in GenBank, followed by assembly into contigs and analysis 
with the STADEN (version 1997.1) and MacVector 7.0 software packages. 
Generation of reporter constructs 
A -3.1 kb mouse MBP/lacZ construct (Foran and Peterson, 1992), was used to 
derive constructs containing -165 bp (Ehe!), -300 bp (Stu!), -377 bp (Apa!), or -794 bp 
(BseRl) of proximal promoter sequence driving lacZ expression. A -9.4 kb construct was 
derived by the addition of a 0.44 kb PvuII-SacII fragment to a previously described -8.9 
kb MBP/lacZ construct (clone 8) (Forghani et al., 2001). Clone 8 was also used to isolate 
a -5.8 to -3.1 kb KpnI-XbaI fragment encompassing M3. Deletion of a 0.6 kb fragment 
containing M3 was perforrned by digestion with AvrII-BglII (spanning -5.0 to -4.4 kb). 
Both -5.8 to -3.1 kb fragments (either containing M3 or not) were in tum ligated 
upstream of the -300 bp proximal promoter sequence coupled to the coding region of 
lacZ. AH of the above MBP-promoted constructs also include either the complete 
previously described Schwann cell enhancer 1 (SCE 1) sequence (SacII-SacI fragment 
from -8.9 to -8.3 kb; (Forghani et al., 2001), or truncated versions of 0.2 kb SCEI 
(BstEII-BglII from -8.8 to -8.6 kb), 0.5 kb SCE 1 (SacII-NaeI from -8.9 to -8.4 kb) or 0.44 
kb ofupstream SCE2 sequence (PvuII-SacIlfrom -9.4 to -8.9 kb; (Forghani et al., 2001), 
as shown in Fig. 1 C. 
Constructs containing M3 alone were generated by ligation of a 0.38 kb BtgI-AvaII 
fragment upstream of either -300 bp of proximal promoter sequence (as above) or a 0.3 
kb HSP68 minimal promoter ligated to lacZ (clone p61OZA; a gift from R. Kothary, 
University of Ottawa). To test whether the two putative Nkx6.2/Gtx sites on the (+) 
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strand of M3 are involved in targeting function, complementary M3 sequence encoding 
oligonuc1eotides bearing mutations that abolish Nkx6.2/Gtx binding (GTTAATGC ~ 
GTTGGCGC and TTTAAITC ~ TTTGGCCC; custom made by Sheldon Biotechnology 
Centre, McGill University) (Awatramani et al., 1997) were annealed and c10ned into M3. 
The mutated sequence (M3 ùnkx6.2) was subsequently ligated to the 5' end of -300 
bp/SCE1. The resultant mutant (M3 ùnkx6.2/-300 bp/SCE1) was confirmed by 
sequencing ofboth strands. 
M4-containing sequences were similarly ligated upstream of the heterologous 
HSP68 minimal promo ter; namely, a mouse 1.1 kb PvuII-PvuII fragment (spanning -9.4 
to -8.3 kb), a mouse 0.4 kb BstXI-AvrIIfragment (spanning -9.1 to -8.7 kb), and a human 
1.0 kb BssSI-EcoRI fragment (spanning -15.5 to -14.5 kb). A construct containing 
modular sequences with minimal surrounding sequence was generated by sequential 
ligation of M4 1.1 kb and M3 (0.38 kb fragment) upstream of -794 bp of proximal 
promoter sequence ligated to lacZ. 
AlI of the above constructs were directionally inserted into a slightly modified 
version of the hprt targeting vector pMP8SKB (a gift from Sarah Bronson, Pennsylvania 
State University). 
Cell culture and electroporation 
BK4-ES cells bearing the hprt docking site (also a generous gift from Sarah 
Bronson) or a derivative on a mixed genetic background (C57Bl/6 and 129) generated in 
our laboratory were grown on gamma-irradiated murine embryonic fibroblasts in high-
glucose DMEM (Life Technologies) supplemented with 15% heat-inactivated FBS, 1% 
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L-glutamine, 1 % MEM amino acids, 1 % sodium pyruvate, 1 % penicillin-streptomycin, 
0.1 mM 2-mercaptoethanol, and 50 ).lI of LIF (Life Technologies). A quantity of 5-7 x 
106 BK4-ES cells were electroporated with 40 ).lg oflinearized DNA (250 V and 500 ).lF, 
Gene Pulser II; Bio-Rad Laboratories). Homologous recombinants were selected on 
HAT -supplemented medium, containing 0.1 mM hypoxanthine, 0.0004 mM aminopterin, 
and 0.016 mM thymidine (Sigma). HAT-resistant colonies were picked 14-21 days later 
for propagation. 
Generation of transgenic mice 
All experiments involving animaIs were conducted in accordance with McGill 
University animal care guidelines. Targeted ES cells were injected into C57BL/6-derived 
blastocysts that were then transplanted into the uteri of recipient females. Resulting 
chimeric males were bred with C57BL/6 females, and the FI agouti female offspring 
were backcrossed with C57BL/6 males. Genotyping was performed by PCR analysis of 
genomic DNA with lacZ coding sequence-specific primers. 
Demyelination/nerve injury models 
To induce spinal cord demyelination, adult female mice (2-3 months of age) were 
injected intrathecally at the L4-5 level with 0.3 J-lg of CTB-Saporin (Advanced Targeting 
Systems) dissolved in sterile 0.9% saline. Tissues were analyzed following a 6 wk 
recovery period. To induce peripheral nerve regeneration, adult male or female mice (2-3 
months of age) were anesthetized and unilateral sciatic nerve crushes were performed 
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(2X 10 seconds) at mid-thigh level with a No. 5 forceps. Sciatic nerves were analyzed at 
14 or 21 days post crush (dpc) injury. 
Histochemical detection of ~-galactosidase activity 
Histochemical staining was perforrned as described previously (Forghani et al., 
2001). Briefly, mice were anesthetized and perfused transcardially with 0.5% 
paraforrnaldehyde, 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Following 
post-fixation for an additional hour, whole mounts or tissue sections (brain, spinal cord, 
or dorsal root ganglia) were incubated at 37°C in staining solution containing 5 mM 
potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM magnesium chloride, 
0.02% Nonidet P-40, and 0.4 mg/ml Bluo-Gal (Sigma). 
Microscopy 
Stained whole mount specimens and spinal cord vibratome sections were viewed 
on a Wild M5A stereomicroscope and photographed with a Zeiss AxioCam HRc. 
Adjacent vibratome sections were embedded in epon. Following trimming, semi-thin (1 
/-lm) and thin (10 nm) sections were prepared using an ultramicrotome (Reichert Jung), 
and processed for light microscopy and electron microscopy (Phillips CM -10), 
respectively. 
Quantitation of ~-galactosidase expression levels 
Cervical spinal cords were dissected from C57B1/6 backcrossed P18 mice and 
homogenized with two 10 second bursts of a Polytron homogenizer in 10 volumes (0.7 
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ml) of lysis solution (100 mM potassium phosphate, 0.2% Triton-X-100). Total prote in 
concentrations were then measured for aIl extracts in triplicate by the Bradford 
microassay procedure (Bio-Rad). Two separate methodologies were employed for 
quantitation of activity levels. Absolute activity levels differed in the two techniques but 
relative levels were conserved. The Galacto-Star chemiluminescent assay system 
(Applied Biosystems) with readings performed on a Revelation MLX luminometer 
(Dynex Technologies) was used following manufacturer's instructions for comparison of 
expression levels from independently derived transgenic lines bearing identical constructs 
(Fig. 4A, inset). The fluorescent substrate DDAO galactoside (Molecular probes) with 
quantitation using the Typhoon phosphorimager and ImageQuant software (Molecular 
Dynamics) was used for comparison of activity levels between different constructs (Fig. 
4A). Standard curves were generated by assaying seriaI dilutions of ~-galactosidase 
(Roche Diagnostics) in triplicate. 
RESULTS 
Human-mouse sequence comparison reveals four conserved modules 
To search for evolutionarily conserved MBP regulatory elements, human (25 Kb) 
and mouse (12 kb) 5' flanking sequences were sequenced and compared. Figure lA 
shows a percentage identity plot (PIP) generated by the PIPMaker pro gram (Schwartz et 
al., 2000), with the human sequence represented on the x-axis. This comparison revealed 
a relatively high level of interspecies polymorphism equivalent to that observed at the 13-
globin locus (Hardison et al., 1997). Using the threshold criteria of75% identity over 100 
bp, four conserved modules were identified. These range in length from 106 bp to 369 bp 
12 
(Fig. lB) and demonstrate percent identities of 87%, 78%, 79%, and 82% (Ml to M4, 
respectively). AlI inter-modular sequences are longer in human than in mouse with 
further human-mouse conservation present only in short sequences «30 bp), typically 
adjacent to the modules (as defined by the above criteria). 
We further evaluated the modular sequences for the presence of known regulatory 
elements linked to MBP regulation. We searched for such elements using both 
MacVector 7.0 software and the Transcription Factor Database (TRANSFAC; 
http://transfac.gbf.de/TRANSFAC/) (Wingen der et al., 2001). Over 250 experimentally 
characterized murine cis-regulatory sites were recognized in Ml to M4 including putative 
high-affinity recognition sites for the glial-associated factors Krox-20IEgr2, Sox-lO, and 
Nkx6.2/Gtx. 
The hprt locus does not deregulate MBP-promoted reporter gene expression in 
myelinating glia 
To determine if regulatory function is conferred by the conserved non-coding 
MBP sequences, we applied a controlled transgenesis strategy permitting direct inter-
construct comparisons of both qualitative and quantitative regulatory phenotypes. 
Reporter constructs containing different configurations of modular and inter-modular 
sequence were inserted, in single-copy and in a known orientation, at a predetermined 
site at the hprt locus (Bronson et al., 1996; Cvetkovic et al., 2000; Vivian et al., 1999) 
(Fig. 1 C). We show first that the chosen hprt docking site provides a transcriptionally 
favorable environment with representative constructs displaying spatiotemporal 
expression patterns paralleling that observed with multiple independently-derived random 
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insertion transgenic lines. A relatively weak MBP promoter (-3.1 kb) (Foran and 
Peterson, 1992) drives readily detectable reporter gene expression (Figures 2A,B,E,F) 
while stronger promoters (-9.4 kb, Fig. 2C,G; and -8.9 kb, see below) drive markedly 
higher expression levels. These hprt-docked constructs also contain the previously 
described SCE 1 sequence which, as again expected from numerous random insertion 
lines (Forghani et al., 2001), targets continuous high-Ievel Schwann cell expression. 
Despite ubiquitous expression of the endogenous hprt gene, its 5' flanking 
sequence provides a relatively neutral environment. A sensitive hprt-docked enhancer 
trap construct, regulated by 0.3 kb of the HSP68 promoter, is expressed only in 
cardiomyocytes (data not shown) and blood vessels (including in the CNS; Fig. 2D,H) 
and, at trace levels, in spinal cord dorsal gray matter (data not shown). Thus hprt-
associated enhancers do not drive expression in myelinated glia or neurons. Although 
further features of the hprt-docking site chromatin and regulatory environment remain to 
be elucidated, this circumstance supports the use of direct inter-construct regulatory 
pro gram comparisons made throughout this investigation. 
Multiple pathways mediate oligodendrocyte targeting during development 
The design of reporter constructs analyzed here was based upon the modular 
structure of conserved MBP 5' flanking sequence. Subsequent analysis of reporter gene 
expression was performed in either tissue sections or whole mount preparations of spinal 
cords and brain (oligodendrocytes), or spinal roots and sciatic nerves (Schwann cells). 
Expression was analyzed mainly at P18, corresponding to peak MBP rnRNA 
accumulation in the CNS (Mathisen et al., 1993), at multiple mature ages when stable and 
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lower MBP mRNA levels are observed, and in the remyelinating CNS and PNS of 
mature mice. 
To begin, we evaluated the putative regulatory function of Ml and M2 sequences 
using a series of proximal promo ter sequences extending to -794 bp. No oligodendrocyte 
expression was detected from constructs regulated by either -165 bp (data not shown) or-
300 bp (Fig. 3F, see below) of proximal promoter sequence. In contrast, extending the 
promoter to -377 bp, and thus inc1uding the complete Ml sequence, leads to expression 
in oligodendrocytes during primary myelination (Fig. 3A) which shuts off by about P30 
(data not shown). The sequence extending to -794 bp, and thus inc1uding M2, results in 
higher levels of reporter gene expression at P18 (Fig. 3B, see below) and extends the 
period of expression (Fig. 3C) (construct also differs in content of truncated Schwann cell 
enhancer sequences ligated 3'of lacZ). Like the Ml-regulated construct, expression in 
oligodendrocytes is transient and, at three months of age, only a small oligodendrocyte 
sub-population expresses the -794 bp regulated reporter (data not shown). 
To determine whether M3 has regulatory function, a series of five constructs was 
evaluated. In contrast to Ml- or M2-containing constructs, a construct bearing the 0.38 kb 
M3-containing sequence, ligated to the heterologous HSP68 promoter, was expressed at 
high-levels not only in juvenile mice but throughout maturity and senescence (Fig. 3D, 
E). Further, an identical CNS expression pattern is observed when either the 0.38 kb or a 
2.7 kb (from -5.8 to -3.1 kb) M3-containing sequence is ligated to the non-targeting 
(minimal) -300 bp MBP promoter (Fig. 3F,G,H). Finally, a construct otherwise identical 
to that bearing the -5.8 to -3.1 kb sequence but deleted of a 0.6 kb M3-containing 
fragment, fails to express in oligodendrocytes at any age (Fig. 31). 
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Taken together, these results demonstrate that major oligodendrocyte targeting 
functions reside within the first three MBP modules, corresponding to a total of 0.7 kb of 
conserved sequence. Depending upon the stage of CNS maturation, MI, M2, and M3 all 
contribute to oligodendrocyte expression. While Ml- and M2-containing constructs are 
expressed robustly in oligodendrocytes of juvenile mice during primary myelination, M3 
al one drives continuous expression in the mature CNS. 
Ml and M2 fail to target expression during adult CNS remyelination 
A demyelinating in suit in the mature CNS results in local maturation of 
oligodendrocyte progenitors that subsequently initiate expreSSIOn of myelin genes 
(inc1uding MBP) and partially remyelinate denuded axon segments. Amongst MBP-
regulated constructs that express in oligodendrocytes during primary development, the -
3.1 kb regulated construct fails to be re-activated in such newly-myelinating adult brain 
oligodendrocytes while a -8.9 kb regulated construct is expressed robustly (Finsen and 
Peterson, unpublished observations). Using a novel spinal cord demyelination strategy 
(Jasmin et a1., 2000), we show here that neither the -3.1 kb (Fig. 4A,C) nor the -794 bp 
sequence (Fig. 4B,D) drive expression in newly myelinating oligodendrocytes analyzed 
at six weeks following the demyelinating in suit. ~-galactosidase histochemicallabeling 
and electron microscopic analysis of adjacent spinal cord cross-sections reveals no 
detectable activity in oligodendrocytes elaborating thin compact myelin sheaths typical of 
adult remyelination. Taken together, these results suggest that M3, essential for 
expression throughout myelin maintenance, may also be required for MBP expression 
during myelin repair in the adult CNS. 
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M3 and M4 targeting to myelinating Schwann cells depends on combinatorial 
interactions 
MBP also is expressed by Schwann cells myelinating PNS axons and the 
previously designated 0.6 kb SCEI sequence (Forghani et al., 2001) located at -8.9 to -
8.3 kb partially overlaps M4 (-9.1 to -8.7 kb). AlI hprt-docked constructs containing M4, 
including minimally promoted constructs, express in myelinating Schwann cells during 
both primary development and regeneration following sciatic nerve crush (Fig. SA,B,F). 
Further, constructs regulated by the human M4 sequence also express robustly, 
demonstrating multiple levels ofhuman-mouse conservation in the mechanism regulating 
Schwann cell MBP expression (Fig. SC,D). 
Our combined data provide strong evidence that major MBP regulatory sub-
programs are conferred through each of the modules identified by sequence conservation. 
In addition, in the course of these functional studies, evidence of combinatorial regulatory 
control extending beyond individual modules was encountered. Previous investigations 
showed that MBP S' flanking sequences initiating at the proximal promoter must extend 
into M4 to confer Schwann cell expression (Foran and Peterson, 1992; Forghani et al., 
2001; Gow et al., 1992). Thus, it was unexpected that a construct bearing only M3 
sequences would drive expression in Schwann cells. Nonetheless, when isolated from 
adjacent inter-modular sequences, M3 drives robust, albeit transient, Schwann cell 
expression during both development and sciatic nerve remyelination (Fig. SE,G,H). As 
the control HSP68 construct is not expressed in either developing or remyelinating sciatic 
nerve Schwann cells (Fig. SI), this activity is attributable to M3 alone. 
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Further evidence for combinatorial regulatory control was revealed for M4-
containing constructs. When divorced from further MBP sequence, M4-containing 
constructs express ectopically in satellite glia of dorsal root ganglia (Fig. 5A-D and data 
not shown), whereas the -9.4 kb construct shows no such expression (Fig. 2C). The M4 
LI kb/M3/M2/MI construct (which contains all the modules with only minimal 
surrounding sequence) reveals a regulation pro gram similar to that conferred by 
contiguous MBP sequences extending to -9.4 kb and, as observed in the chimeric 
preparation shown in Figure 6, appears not to express in satellite glia. Thus, elements 
serving to constrain the spectrum of glial cell types expressing MBP also likely reside 
within modular sequences. 
The un-masked M3 Schwann cell enhancer activity and the M4-mediated satellite 
cell targeting suggest that either inter-modular or modular sequences can serve to restrict 
the cell-specific enhancer function contained in modular sequences. As combinatorial 
regulatory activity underlies the above two targeting phenotypes, it raised the possibility 
that such interactions might also regulate quantitative phenotypes. 
Quantitative comparison of hprt-docked reporter gene expression levels 
For the well-characterized endo-1610cus of sea urchin (Bolouri and Davidson, 2002; 
Yuh et al., 1998, 2001), quantitative functions have been shown to play a major role in 
the overall cis-regulatory program. To determine if MBP regulatory sequences similarly 
display a variety of complex quantitative phenotypes, we first set out to validate 
quantitative comparisons between hprt-docked constructs by determining whether 
independently derived transgenic lines bearing identical constructs accumulate similar 
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levels of J3-galactosidase. Figure 7 (inset) shows that pairs of transgenic lines derived 
from independent embryonic stem cell clones bearing either -3.1 kb/SCE1, -8.9 kb, or -
9.4 kb constructs display similar J3-galactosidase activity levels (across the broad range of 
quantitative phenotypes predicted from the histochemical preparations). Thus, we 
conclude that differences in inter-construct J3-galactosidase activity levels can be reliably 
ascribed to the complement of regulatory elements contained within each construct. 
Our investigations reveal extensive quantitative modulation since mice bearing 
the various constructs demonstrated a wide range of oligodendrocyte J3-galactosidase 
activity levels (Fig. 7). There is an approximately 25-fold difference between the 
expression levels of the -377 bp/SCEI (0.2 kb) and -9.4 kb transgenic lines. In particular, 
significant enhancement appears to be conferred through modular activity mediated by 
M3. For example, the M3/hsp and M3/-300 bp/SCEI lines have J3-galactosidase activity 
levels approximately 8-fold that of -794 bp/SCE2 (0.44 kb) and 36% that of the -9.4 kb 
line. In addition, certain inter-modular sequences also appear to be associated with 
significant quantitative activity; the -(5.8-3.1) kb/-300 bp/SCEI transgenic line displays 
approximately 2.1-fold J3-galactosidase activity as compared to the M3/-300 bp/SCEI 
line, possibly related to short conserved sequences lying adjacent to M3. 
To identify functional regulatory elements in vivo, we extended our quantitative 
analysis to examine the potential contribution of putative binding sites for transcription 
factors already implicated in oligodendrocyte maturation. We initially focused on 
putative sites within M3, as we show that it is the dominant regulator of transgene 
expressIOn In mature oligodendrocytes. Nkx6.2/Gtx is an oligodendrocyte-specific 
homeodomain protein known to avidly bind T AA T containing consensus sites 
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(Awatramani et al., 2000; Awatramani et al., 1997). Two evolutionarily conserved 
putative Nkx6.2/Gtx binding sites (both containing the essential TAAT core) on the (+) 
strand of M3 were mutated in a manner to abolish binding (Awatramani et al., 2000; 
Awatramani et al., 1997). The resultant M3 8nkx6.2/-300 bp/SCEI construct (bearing the 
M3 sequence mutations GTTAATGC ~ GTTGGCGC and TTTAAITC ~ TTTGGCCC) 
retains continuous oligodendrocyte targeting activity (data not shown). However, 
quantitative analysis at P18 reveals a statistically significant decrease (~35%) in 
oligodendrocyte B-galactosidase activity levels (Fig. 7). Thus, Nkx6.2/Gtx (or related 
Nkx homeodomain prote in) mediated regulation through these elements is not essential 
for M3 oligodendrocyte targeting function but transcriptional efficiency in vivo is finely 
modulated through transcription factor binding at one or both of these two homeodomain 
sites. 
DISCUSSION 
Multiple modules differentially regulate MBP expression in oligodendrocytes 
In this investigation, we have validated and applied an efficient strategy for the in 
vivo identification and functional characterization ofMBP regulatory sequences. Initially, 
comparison of large regions of human and mouse MBP non-coding sequences identified 
four widely-spaced conserved non-coding modules, totaling ~ 1 kb in length. Using a 
novel targeted transgenesis paradigm that allows for single-copy insertion at the hprt 
locus, each module was shown to confer a unique cell-targeting and quantitative gene 
programming function, seemingly irrespective of absolute spacing from the 
transcriptional start site. A model summarizing the basic combinatorial targeting and 
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quantitative programs of the MBP regulatory system is presented in Figure 8. Taken 
together, our results demonstrate that three MBP modules differentially control major 
cell-state dependent targeting activities and expression levels during CNS primary 
myelination and myelin maintenance while modular and inter-modular interactions 
contribute to maintain glial specificity. 
Several in vivo studies have focused on the MBP proximal promoter region and 
together have demonstrated that short segments are sufficient to activate oligodendrocyte-
specifie and developmentally-regulated reporter gene expression (Goujet-Zalc et al., 
1993; Gow et al., 1992; Miskimins et al., 1992; Turnley et al., 1991; Wrabetz et al., 
1998). Other studies, using similar promoters, have revealed ectopie expression in a 
number of non-neural tissues (Asipu et al., 2001; Y oshioka et al., 1991). In this study of 
hprt-docked constructs, the shortest segment mediating oligodendrocyte-specific 
targeting was the M1-containing -377 bp sequence, and it conferred activity only during 
the postnatal period encompassing primary CNS myelin deposition. Truncation of Ml (-
300 bp, Figure 3F; and -165 bp, data not shown) led to complete loss of oligodendrocyte 
targeting. It is notable that the first 138 bp of the MBP promoter also is a widely 
expressed exon included in an overlapping transcriptional unit (Campagnoni et al., 1993). 
Thus, conservation in this portion of Ml likely includes constraints imposed by this 
coding function. In contrast to the present findings, a previous study (Goujet-Zalc et al., 
1993) using random insertion transgenesis, reported oligodendrocyte targeting from a 
construct regulated by the same -300 bp promoter sequence. However, construct 
multimerization and enhancer trapping are cornrnonly observed at random insertion 
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transgene loci, potentially leading to novel regulatory element interactions (Heard et al., 
1999). 
Extension of proximal promoter sequence to include M2 as weIl as Ml (with the -
794 bp construct) increases oligodendrocyte reporter gene expression (~37%) at P18 and 
modestly extends the period of expression, at least in a subpopulation of 
oligodendrocytes. Only M3-containing constructs were uniformly expressed at high 
levels in oligodendrocytes throughout primary development, adulthood, and senescence. 
At P18, the M3/hsp construct (which contains no other MBP sequence except the 0.38 kb 
fragment encompassing M3) was expressed at ~8-fold the level of the -794 bp construct 
and at ~36% that of the -9.4 kb construct (which contains the entire complement of 
modules). Thus, M3 appears to be the primary regulator of MBP expression both in terms 
of enhancing expression levels during primary mye lin deposition and independently 
regulating expression during myelin maintenance. 
These findings are consistent with previous reports demonstrating that proximal 
promoter sequences, up to -1.3 and -3 kb in length, targeted low level expression to 
myelinating oligodendrocytes that was attenuated with maturation (Foran and Peterson, 
1992; Miskimins et al., 1992; Wrabetz et al., 1998). In contrast, a randomly integrated -
1.9 kb proximal promoter sequence did confer high-Ievel oligodendrocyte reporter gene 
expression in adult mice (Gow et al., 1992). Either the unpredictable effects of copy 
number or integration site account for this or the -1.9 kb promoter contains a unique 
combination of enhancer and repressor elements not revealed by the CUITent analysis. We 
consider the second scenario less likely as the intervening region between -1.9 kb and M2 
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contains no modular sequence and there is minimal difference between the quantitative 
phenotypes ofthe -3.1 kb-and -794 bp-promoted constructs. 
Throughout this investigation, targeted hprt targeting made it possible to use 
inter-construct comparisons to assign precise quantitative phenotypes. Analysis of these 
quantitative results suggests that most of the differences may derive from a simple 
additive relationship amongst the regulatory sequences. Notably, addition of the activities 
derived from constructs regulated by individual modular sequences results in a value 
approximating half that observed for the contiguous -9.4 kb sequence. This difference 
may indicate either the influence of combinatorial relationships or the exclusion of 
relevant sequence from the defined modules. The relatively large quantitative difference 
observed for M3 alone versus M3 in the context of a further 2.3 kb of sUITounding 
sequence is consistent with the latter circumstance and suggests that not aIl functional 
regulatory sequences are grouped into distinct modules. 
Among the few factors directly implicated in the coordinated activation of myelin 
gene expression, the homeodomain prote in Nkx6.2/Gtx in particular has been shown to 
be expressed exclusively in differentiated oligodendrocytes (Awatramani et al., 1997). 
Notably, its temporal expression profile paraIlels that of myelin specific rnRNAs in 
multiple ceIl states (Awatramani et al., 1997; Sim et al., 2000). In addition, in vitro assays 
have demonstrated that Nkx6.2/Gtx binds to a number of recognition sites within both 
MBP and PLP proximal promoters, although none of the MBP putative sites previously 
examined encode a high-affinity TAAT core (Awatramani et al., 2000; Awatramani et al., 
1997). In contrast, M3 contains three such T AA T core domains and a construct bearing 
mutations in the two sites contained within the (+) strand shows decreased expression 
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levels at P18 (Fig. 7). Thus, Nkx6.2/Gtx (or related homeodomain proteins) appears to 
function within a complex network of factors impinging on M3 in oligodendrocytes. 
Investigations are ongoing to unmask the contributions to transcriptional efficiency by 
the remaining TAAT as weIl as other putative binding sites within M3. 
Newly-myelinating adult oligodendrocytes do not recapitulate the developmental 
recruitment of MBP modules 
CNS lesions in experimental demyelination and in diseases such as MS show 
delayed and frequently incomplete remyelination (Franklin, 2002). While no 
susceptibility locus has so far been unequivocally identified for MS, strong evidence 
points to the involvement of genetic factors (Pihlaja et al., 2003). Abortive adult 
remyelination could result from deficient recruitment of oligodendrocyte precursors 
(which involves both migration and proliferation), a relative decrease in the rate of 
differentiation of recruited precursors into myelination competent adult oligodendrocytes, 
altered myelin protein gene regulation, or a combination thereof (Franklin et al., 1997; 
Gensert and Goldman, 1997). 
Our results suggest that the M3 elements that independently mediate expression 
throughout myelin maintenance in the uninjured adult may also be recruited for 
expression in newly-myelinating oligodendrocytes in the adult following a demyelinating 
in suIt. While Ml and M2 drive expression during development in the CNS, they neither 
maintain expression in the adult nor re-initiate expression following a demyelinating 
injury (Fig. 4). The differential MBP modular recruitment exhibited by newly-
myelinating adult oligodendrocytes suggests that the limited remyelination capacity seen 
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throughout the CNS, across species and in numerous disease states, may thus involve 
critical differences in the programming of essential myelin genes as compared to primary 
development, possibly reflecting different transcription factor repertoires. 
Schwann cells demonstrate a distinct pattern of modular recruitment 
We showed previously that the M4-overlapping SCE1 sequence was both 
necessary and sufficient for developmentally regulated targeting to myelinating Schwann 
cells (Forghani et al., 2001). The experimental paradigm used here revealed additional 
Schwann cell enhancer activity within M3. This activity transiently targets expression to 
primary myelinating and adult remyelinating Schwann cells, coincident in both cases 
with the rapid phase of myelin deposition. In contrast to M4, which can target robustly 
during development and remyelination independent of any other MBP sequences, M3 
activity is revealed only when it is isolated from other MBP sequences. While its 
Schwann cell enhancer role in the context of the endogenous locus remams to be 
established, M3 interacts specifically with Schwann cell transcription factors during 
myelin elaboration and therefore can be used effectively as a probe or marker for factors 
expressed at this maturation stage. 
Conclusion 
Our observations identify a complex of sequence motifs through which MBP 
expression is differentially controlled in the CNS and PNS during primary myelination, 
myelin maintenance, and de nova myelin formation in the adult. In addition to pro vi ding 
a tool to target precisely pre-determined levels of exogenous gene products to 
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myelinating glia, we believe it likely that such motifs will serve as effective probes 
leading to the identification of the relevant transcription factors engaged in such different 
glial states as seen during development, maturity, or following myelin perturbations 
secondary to genetic alterations or in jury. Through such associations, linking myelin gene 
regulation to cellular signaling may then be possible (Stolt et al., 2002). 
Finally, although it is likely that many strategies will be used in the functional 
analysis of regulatory sequences, this investigation demonstrates the effectiveness of the 
controlled hprt transgenesis technique in assigning both qualitative and quantitative in 
vivo regulatory phenotypes. With the emergence of the complete genome sequences for 
human, mouse, and other organisms (Lander et al., 2001; Venter et al., 2001; Waterston 
et al., 2002), comparative analysis can be applied on a genome-wide scale (Deloukas et 
al., 2001; Mural et al., 2002). As similar levels of functional understanding are achieved 
with further model loci, new insights into genome organization and the structure of 
regulatory networks appear likely. 
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Figure 1. Human-mouse sequence comparison identifies putative regulatory modules 
evaluated in reporter constructs. A, Alignment ofhuman (25 kb) and mouse (12 kb) MBP 
5' flanking sequences using the PIPMaker software. The human genomic sequence is 
represented on the x-axis and its percentage identity to the mouse sequence (from 50% to 
100%) on the y-axis. This analysis reveals similarly ordered and oriented conserved 
sequence modules. Modular sequences, represented in distinct colors, are designated as 
module 1 through 4 (Ml to M4) proceeding 5' from the proximal promoter. In addition, 
an interspersed repeat lies at -19 kb of the human sequence. B, ClustalW alignment 
(MacVector 7.0) reveals that the individual modules vary in length from 106 to 369 bp in 
the mouse (lower limit of 75% sequence identity over at least 100 bp). Numbering is 
from the initiator ATG. C, Schematic representation, drawn to scale, of reporter 
constructs inserted in single copy at the mouse hprt locus. Enlarged boxes, colored as in 
panel (A), correspond to the conserved modules in their entirety. Inter-modular MBP 
sequences and HSP68 promoter sequences are represented in gray and black, 
respectively. SCE1 and SCE2 sequences (Forghani et al., 2001) are both represented in 
blue and gray. Human M4 is denoted by the symbol h. AlI constructs are ligated to a lacZ 
reporter gene. 
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Figure 2. The hprt docking site is permissive and does not de-regulate MBP targeting in 
myelinating glia. A, E, As predicted from pronuclear lines (Foran and Peterson, 1992; 
Forghani et al., 2001), a LacZ reporter construct driven by -3.1 kb of proximal promoter 
sequence and SCEI is expressed in spinal cord (SpC) and brain oligodendrocytes and 
spinal root (SpR) Schwann cells of P18 mice (arrows). B, F, As observed with randomly 
integrated constructs, -3.1 kb-mediated oligodendrocyte expression gradually shuts off in 
adults while high level SCEI-mediated Schwann cell expression is maintained (shown at 
6 wks). C, G, A reporter construct driven by -9.4 kb, and thus containing the full 
complement of recognized evolutionarily conserved sequence, is expressed at high levels 
in myelinating cells throughout development and maturity (shown at 12 wks). D, H, LacZ 
driven by the 0.3 kb HSP68 minimal promoter alone is expressed at high-levels only in 
CNS endothelial cells, with no detectable expression in either oligodendrocytes or 
Schwann cells (shown at 6 wks) . 
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Figure 3. Multiple pathways mediate oligodendrocyte targeting during primary 
myelination. A, B, LacZ regulated by -377 bp/SCEI (0.2 kb), which inc1udes Ml, or -794 
bp/SCE2 (0.44 kb), which inc1udes both Ml and M2, is expressed in spinal cord 
oligodendrocytes at P18. C, -794 bp/SCE2 (0.44 kb) mediated oligodendrocyte 
expression gradually shuts off in the adult (shown at 6 wks), in a pattern similar to that 
seen for the -3.1 kb/SCEI construct. D, E, M3 has autonomous oligodendrocyte targeting 
ability. A 0.38 kb M3 fragment ligated to the HSP68 minimal promoter (0.3 kb) drives 
high level expression in spinal cord oligodendrocytes (shown at Pl8 and 24 wks, 
respectively). F, A truncated version of Ml (-300 bp) does not drive oligodendrocyte 
expression (shown at PI8). G, H, Addition of either 0.38 kb or 2.7 kb (spanning from -5.8 
to -3.1 kb) module-3-containing sequences to -300 bp MBP results in high level and 
continuous oligodendrocyte expression throughout development and adulthood (shown at 
PI8). I, An otherwise identical construct, deleted of a 0.6 kb sequence spanning M3 
(from -5.3 to -4.7 kb) fails to express in oligodendrocytes throughout deve10pment and 
adulthood (shown at PI8). Constructs represented in (F-I) contain the SCEI sequence 
ligated 3' of the lacZ gene, accounting for expression in Schwann cells (Forghani et al., 
2001). 
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Figure 4. Ml and M2 do not drive expression in newly myelinating oligodendrocytes in 
adults. A, B, LacZ reporter constructs bearing -3.1 kb/SCEI (0.5 kb) or -794 bp/SCE2 
(0.44 kb), respectively, fail to express in newly myelinating adult oligodendrocytes six 
wks following spinal cord demyelination induced by intrathecal injection of CTb-saporin 
(Jasmin et al., 2000). C, D, Sections adjacent to histochemical preparations were 
processed for electron microscopy with boxed are as in (A-B) sampled in (C-D), 
respectively. Variable B-galactosidase labeling is observed across the section but areas 
devoid of labeling contain profiles typical of newly-myelinating oligodendrocytes (boxed 
areas at 900X shown at 6300X on right). 
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Figure 5. M3 and M4 individually target expression to myelinating Schwann cells. A, C, 
Reporter constructs M4 1.1 kb/hsp, M4/hsp, M4 1.0 kb (human)/hsp all demonstrate high 
level expression in spinal root Schwann cells throughout primary development and in the 
adult (all shawn at 12 wks). D, A randomly inserted M4 1.0 kb (human)/hsp reporter 
construct similarly results in high-Ievel Schwann cell expression (shown at 12 wks). E, 
The M3/hsp reporter construct drives high level expression in spinal root Schwann cells 
but only during active myelin formation in primary development (shown at PlO). F, The 
M4 1.1 kb/hsp construct is expressed at high levels in both mature (left of arrow) and 
remyelinating (right of arrow) Schwann cells (shown at 21dpc). G, H, The M3/hsp 
construct also drives expression in Schwann cells during the initial phase of 
remyelination following sciatic nerve crush injury but gradually shuts off (portion of 
nerve to right of arrow), shown at 14 and 21 dpc, respectively. I, The control HSP68-
promoted construct fails to express in either mature or remyelinating Schwann cells 
(shown at 14 dpc). 
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Figure 6. Combined Ml to M4 targeting profile parallels that of -9.4 kb construct. The 
M4 1.lkb/M3/M2/MI construct is expressed at high levels throughout development and 
maturity in both oligodendrocytes and Schwann cells but not in dorsal root ganglia 
(shown here in a chimera at 6 wks). 

Figure 7. Multiple comparisons of ~-galactosidase activity levels between transgenic 
lines validates quantitative analysis of hprt-docked reporter genes. Inset demonstrates 
that independently derived transgenic lines bearing the same construct at the hprt locus 
accumulate similar levels of ~-galactosidase (units/!lg total protein) in oligodendrocytes 
(comparisons between pairs of transgenic lines derived from independent ES clones 
bearing -3.1 kb/SCE1, -8.9 kb, and -9.4 kb constructs are shown). Comparisons of the 
expression levels achieved by the -9.4 kb reporter construct and constructs regulated by 
variously truncated MBP sequences demonstrate that significant enhancer activity is 
associated with all four modules. 
-377 bp/SCE 1 
(0.2 kb) 
-794 bp/SCE2 
(0.44 kb) 
-3.1 kblSCE1 
M3/hsp 
M3I-300 bpi 
SCE1 
M3 dnkx6.21 
-300 bp/SCE 1 
-(5.8-3.1) kbl 
-300 bp/SCE 1 
-9.4 kb 
0 0 
0 0 
0 
-
1\) 
1 
Beta-galactosidase activity 
(units/~g total protein) 
0 0 0 0 0 0 0 0 0 0 0 g 0 0 0 w .. (JI -...j co co ..... 
0 0 0 
0 :.... Ï\) i:,,) 
-3.1 kb/SCE1 
-8.9 kb 
-9.4 kb 
Figure 8. Modular organization of the MBP cis-regulatory system. Schematic 
representation of recognized regulatory programs conferred by MBP modular sequences. 
Targeting activity is represented by solid arrows in oligodendrocytes (OL) and Schwann 
cells (SC). Potential inter-modular regulatory activity is represented by dotted lines. 
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CHAPTER3 
PREFACE 
This chapter presents data characterizing the functional organization of one of the MBP 
5' flanking modules, module 4 located approximately 9 kb upstream of the transcriptional 
start site. As such, it represents one of several ongoing second generation studies 
evaluating the function of evolutionarily conserved regulatory motifs within a module. As 
seen for the sea urchin endo-16 locus, enhancer activity requires contributions from a 
highly conserved targeting core as well as multiple flanking elements, with the latter 
modulating activity in a developmentally contextual manner. 
FUNCTIONAL ORGANIZATION OF A SCHWANN CELL ENHANCER 
Eric Denarier, Reza Forghani, Hooman F. Farhadi, Samar Dib, Nancy Dionne, Hana 
Friedman, Pierre Lepage, Thomas 1. Hudson, Régen Drouin and Alan C. Peterson 
Submitted to the Journal ofNeuroscience 
ABSTRACT 
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Myelin genes coordinately up regulate expreSSIOn at the initiation of mye lin 
formation, reach peak levels pre-weaning and maintain lower levels throughout maturity. 
For the Myelin Basic Protein (MBP) gene, this expression pro gram is conferred in 
oligodendrocytes and Schwann cells through different upstream enhancers. In Schwann 
cells, expression is controlled by a 422 bp enhancer shown here to contain 22 mammalian 
conserved motifs 2: 6 bps. To investigate their functional significance, different 
combinations of wild type or mutated motifs were introduced into reporter constructs that 
were inserted in single copy at a common HPRT docking site in ES cells. Lines of 
transgenic mice were derived and the subsequent qualitative and quantitative expression 
phenotypes were compared at different stages of maturation. In the enhancer core, seven 
contiguous motifs cooperate to confer Schwann cell specificity while different 
combinations of flanking motifs engage, at different stages of Schwann cell maturation, 
to modulate expression level. Mutation of a Krox-20 binding site reduces the leve1 of 
reporter expression while mutation of a potential Sox element silences expression. The 
potential Sox motif also was found conserved in other Schwann cell enhancers suggesting 
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that it contributes widely to regulatory function. Our results demonstrate a close 
relationship between phylogenetic footprints and regulatory function and suggest a 
general model of enhancer organization. Finally, this investigation demonstrates that in 
vivo functional analysis supported by controlled transgenesis can be a robust complement 
to both molecular and bioinformatics approaches to regulatory mechanisms. 
INTRODUCTION 
Rapid conduction of action potentials is conferred to large vertebrate axons by 
their myelin sheaths. In the peripherai nervous system (PNS), myelin is elaborated and 
maintained by Schwann cells in response to axonal signaIs (LeBlanc and Poduslo, 1990). 
Coincident with initiation of myelin formation, genes such as myelin basic protein 
(MBP), myelin protein zero (PO), and peripheral myelin protein 22 (PMP22) are 
coordinately up-regulated (Stahl et al., 1990). Demonstrating the essential role played by 
myelin in PNS function, acquired or inherited disruptions in the formation or 
maintenance of myelin leads to weIl characterized and often severe neuropathies (Keller 
and Chance, 1999). 
Several transcription factors are known components of the mechanism engaged to 
regulate Schwann cell differentiation. In the absence of the zinc finger transcription 
factor Krox-20, or the POU-domain transcription factor Oct-6, Schwann cells arrest at the 
promyelinating stage (Bermingham et al., 1996; Topilko et al., 1994). In Oct-6 mutants 
myelination resumes following a two-week pause while in Krox-20 mutants this block is 
insurmountable. Sox-10, known to cooperate with Oct-6 (Kuhlbrodt et al., 1998) and 
Krox-20 (Bondurand et al., 2001), also is required for myelin formation (Britsch et al., 
2001). Thus, differentiation of the Schwann celllineage is controlled through a regulatory 
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network of transcription factors acting at multiple stages of Schwann cell maturation. 
Also, evidence from in vitro studies suggests that these same factors may regulate 
individual myelin genes at later stages of maturation (Musso et al., 2001; Peirano et al., 
2000). 
Previous investigations designed to identify the regulatory sequences controlling 
mye lin gene expression in Schwann cells exploited reporter constructs containing specific 
promoter or enhancer sequences. Regulatory sequences from MBP (Farhadi et al., 2003; 
Forghani et al., 2001), PO (Feltri et al., 1999), PMP22 (Maier et al., 2003) and the 
transcription factors Oct-6 (Mandemakers et al., 2000) and Krox-20 (Ghislain et al., 
2002) have been evaluated in transgenic mice. Such functional assays revealed diverse 
expression programs suggesting that myelin gene expression is controlled by a large and 
developmentally contextual transcription factor repertoire. However, neither the precise 
location nor functional relevance of individual elements has been defined clearly for any 
such locus in transgenic animaIs. 
We show here, using a controlled strategy of transgenesis (Bronson et al., 1996), 
that phylogenetic footprints in the MBP Schwann cell enhancer are functional regulatory 
elements. Our findings further suggest a model of enhancer structure in which targeting 
elements are clustered in the enhancer core. Activity from multiple flanking motifs 
combines with the targeting core to confer fine control over cell specificity and 
expression levels. Notable differences in the enhancing elements engaged during myelin 
elaboration and maintenance demonstrate that the MBP expression pro gram is controlled 
by different transcription factor repertoires at different stages of development. By specific 
mutation, we show that a binding site for Krox-20 and a motif with potential Sox-10 
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binding activity play major roles in enhancer function. Further, the Sox motif is 
conserved in other active sequences suggesting that it contributes widely to Schwann cell 
expreSSIOn. 
MATERIALS AND METHODS 
Generation of constructs for HPRT docked transgenesis 
The MBP -9.4 kb and -8.9 kb constructs were described previously (Farhadi et 
al., 2003). The construct -8.98kb was generated by cloning an annealed 80 bp 
oligonucleotide product (custom made by Sheldon Biotechnology Centre, Mc Gill 
University, Montreal, Quebec, Canada) to the SacII site 5' of clone -8.9 kb. To clone 
Mod4 sub-fragments, we first generated an hsp-LacZ Entry vector in which hsp-LacZ is 
cloned into an Eco RV site of the pENTRIA vector (Invitrogen). Mod4 sub-domains 
were ligated upstream of the hsp promo ter in reverse orientation relative to endogenous 
MBP. Entry vectors were used for in vitro recombination into the RPRT Destination 
vector that includes homology arms for the RPR T locus using the LR clonase reaction kit 
(Invitrogen). The final Destination vector was amplified, sequenced across the insert and 
linearized by Age 1. 40 ~g of targeting construct was used to transfect ES cells. Individual 
motif mutations were generated by a two step PCR introducing a TTGTT -7CGAGC 
substitution in 135-M14mut, TGA-7ATT in 135-M16mut, ACAA-7CCGC in SA-
M18mut, and ACA-7GTT in SA-M20mut. 
Derivation of transgenic mice 
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Transgenic animaIs bearing constructs in the HPRT docking site were generated 
by transfection of Destination constructs bearing the HPRT targeting cassette into the 
BK4 (for SA) or BPES5 cells, a laboratory derived heterozygous cell line. Homologous 
recombination simultaneously restores the deleted HPR T locus and inserts a single copy 
of the reporter construct into the HPR T 5' flanking region. Restoration of HPR T 
expression confers resistance to HAT selection thus permitting positive selection for 
clones derived from the desired homologous recombination event. Following selection 
and PCR screening, ES clones were injected into blastocysts. DNA prepared from 
subsequent chimeras or germline females was analyzed by Southem blot to check for 
single integration. 
Remyelination experiments 
To induce peripheral nerve regeneration, 2-month old male mice were 
anesthetized and unilateral sciatic nerve crushes were performed as described (Farhadi et 
al., 2003). The injury site was marked with lndia ink. Following 1, 2, or 4 weeks of 
recovery, injured and contralateral control nerves were harvested and separated into 
similar proximal and distal segments. p-galactosidase activity was measured in distal 
segments and compared to expression levels in uninjured contralateral samples. 
Histochemical detection of p-galactosidase activity 
Histochemical staining was performed as described (Forghani et al., 2001). 
Quantitation of p-galactosidase activity 
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Sciatic nerves were dissected from backcross 2 to 3 C57BL/6 male mice and snap 
frozen in liquid nitrogen. 48 Samples were homogenized using a mixer mill (Qiagen) 
with 2 minute bursts in 250 ~l of lysis buffer. Total prote in concentrations were measured 
for aIl extracts in triplicate by the Bradford procedure (Bio-Rad) using a BSA standard 
curve. ~-galactosidase activity was detected using the Galacto-Star chemiluminescent 
assay system (Applied Biosystems). Standard curves were generated with seriaI dilutions 
of ~-galactosidase (Roche) in duplicate. 
In vivo footprinting 
Peripheral nerves from wild type or Trembler-J (TrJ/+) mice, both on a C57Bl/6 
background, were analyzed. TrJ/+ mice were evaluated here because the chronic 
demyelination/remyelination they experience leads to an enrichment of myelinating 
Schwann cells in their peripheral nerves. First, P4-7 wild type or adult TrJ/+ sciatic 
nerves were harvested, treated with DMS, and their DNA was then processed for Maxam 
& Gilbert sequencing. For in vivo samples, mice were sacrificed and their sciatic nerves 
exposed. Each nerve was then immersed in situ in Ringer's solution containing 0.5% 
DMS for 6 minutes, washed in cold Ca2+ and Mg2+ free PBS for 1-5 min, and finally 
transferred to buffer B+C (approximately 20 nerves per ml). DNA was prepared and 
treated as described (Drouin et al., 2001). A total of 800 bp of Mod4 containing sequence 
was analyzed on both strands using different primer sets. As a sequence marker, genomic 
DNA from liver was also prepared for sequencing. Methylated guanines from DMS 
exposures and chemically damaged DNA were converted into strand breaks by hot 
piperidine treatment. Strand break frequencies were estimated on an alkaline agarose gel 
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(Drouin et al., 1996). Consistent band intensity differences between in vivo and in vitro 
samples in two different experiments were scored as in vivo footprints. 
Sequence analysis 
The rat Mod4 sequence was obtained through the rat genome sequence available 
at http://genome.ucsc.edu/. An MBP containing BAC from the genomic Chicken BAC 
library (BACP AC resource, Oakland Research Institute) was identified using a PCR 
probe for chicken MBP exon 1. Positive clones were identified and amplified. DNA was 
sheared and ligated to pBluescript vectors. Sequences were aligned by ClustalW using 
MacVector 7.0 software. A VISTA plot of the Mod4 sequence was created using the 
VISTA server (http://gsd.lbl.gov/vista/). 
Electrophoretic mobility shift assays 
Oligonucleotide probes were produced by annealing the complementary strands 
and filling the two end overhangs with aP32 dCTP and Klenow. MU 
CTAGCCGGCAGCCACATGCCTTTC, Mllmut CTAGCCGGCAGAATTCT 
GCCTTTC, MI2-5' CTAGTGCCTTTCATAGATGCAGAA, M12-5'mut 
CTAGTGCCTTTGAA TTCTGCAGAA, M14 CTAGGGGCCTTTTTGTTTCCTGTG, 
M14mut CTAGGGGCCTTTCGAGCTCCTGTG, M16 CTAGTCCCAGGTGACCC 
CAAGCCC, M16mut CTAGTCCCAGGATTCCCCAAGCCC, M20 CTAGTA 
GCCGGGCCCACACGCCCA, Krox CTAGGTTGTACGCGGGGGCGGTTAGT. 
Sciatic nerve extracts were prepared as follows: 150 sciatic nerves from PlO mice were 
dissected, extracts were prepared and EMSA reactions (30).11) were performed as 
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described (Forghani et al., 1999). Bacterially expressed Krox was produced from a pET-
Krox plasmid as described (Nardelli et al., 1992). 
RESULTS 
Inter-species sequence comparisons reveal conserved motifs within Mod4 
The MBP 5' flanking sequence contains four non-coding sequences (Modl to 
Mod4) each with humanlmouse conservation extending over 100 bps at 75% or greater 
identity (Farhadi et al., 2003). Mod4 lies approximately 9 kb upstream of the MBP start 
site and corresponds to a 422 bp region of conservation with Schwann cell enhancer 
activity. To reveal motifs that may correspond to functional transcription factor binding 
sites we extended the Mod4 sequence comparison to rat and chicken. Mouse/rat, 
mouse/human, and mouse/chicken comparisons yield respective sequence identities of 
91 %, 76% and 56%. Twenty-two motifs of at least 6 bps (Ml to M22) are conserved in 
many mammalian species and of these, 7 are invariant in the more distantly related 
chicken species (Fig. 1). 
In vivo footprinting reveals protein/DNA interactions in the core Mod4 sequence 
To locate the regions of DNA-transcription factor interaction within Mod4, we 
screened an 800 bp Mod4 containing sequence using the LMPCR based in vivo 
footprinting approach. DNA was derived from sciatic nerve samples from normal mice 
and, to potentially enrich for the population of Schwann cells actively elaborating myelin, 
additional samples were prepared from Trembler-J mice. Sciatic nerves were pre-treated 
with dimethylsulfate and DNA was purified and subsequently analyzed for footprints. 
Within the 800 bp region screened in this analysis, four footprints were detected, aIl 
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located in the core of the conserved Mod4 sequence. One is a protected guanine residue 
in motif 9, and three are hypersensitive sites, one between motif 10 and Il and two in 
motif 15 (Fig. 1 and 2). These observations suggest that a prote in complex binds to the 
most conserved Mod4 region while the sequences surrounding Mod4 lack similar 
interactions with transcription factors. Subsequent DNA-protein interaction analysis and 
functional characterization focused on Mod4, guided by the location ofboth phylogenetic 
and in vivo footprints. 
MBP developmental programming is exposed by species-specific Mod4 expression 
To determine if human and chicken Mod4 sequences are capable of productive 
interaction with mouse transcription factors, each was ligated to an hsp68-promoted LacZ 
reporter gene and investigated for expression in transgenic mice. To eliminate the 
variation associated with random integration at different insertion sites, constructs were 
docked, in single copy and predetermined orientation, in the 5' flanking sequence of the 
hprt locus (Bron son et al., 1996). Mod4 sequences from both species drove reporter gene 
expression in Schwann cells in mature mice (Fig. 3A and B). The human sequence 
conferred a typical post-natal expression phenotype initiating high-Ievel expression at the 
commencement of myelin formation. In contrast, the chicken Mod4 reporter remained 
silent during pre-weaning development, wh en both the en doge nous MBP locus and the 
human Mod4 reporter are highly expressed. Rather, expression of the chicken regulated 
reporter initiated in the peri-weaning period when mye lin formation in the PNS is 
approaching a mature state. Thus, Mod4 elements essential for expression during 
mammalian myelin formation are either non-existent or too divergent in the chicken 
sequence to be recognized by mouse factors. Further, the location of such essential 
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elements must be limited to the polymorphisms existing between the chicken and human 
sequence (Fig. 1). The subsequent expression of the chicken Mod4 reporter in mature 
mice demonstrates that the MBP relevant transcription factor repertoire undergoes 
significant changes as Schwann cells progress from mye lin elaboration to mye lin 
maintenance. 
Mapping of the targeting sequence within Mod4 
To map the location of targeting elements within mouse Mod4, multiple Mod4 
sub-domains were analyzed individually (Fig. 3, A and C). The 5' 210 bps lying between 
Bst XI and Sac II (BS), containing conserved motifs Ml through M9, failed to drive 
Schwann cell expression. In contrast, robust expression was conferred by the 3' 213 bp 
lying between Sac II to Avr II (SA) that contains motifs 10 to 22. Of note, two non-
overlapping fragments of SA, 85 bps containing MIO-M13 and 107bps containing M14-
M20, individually showed no activity. Thus, one or more elements within each fragment 
are needed to confer targeting activity. As a 135 bp sequence containing MIO-M16 drives 
Schwann cell expression, at least one of the essential elements is located within the 50bp 
containing M14-M16. 
Subfragments of Mod4 confer responsiveness to axonal signaling 
In rodents, the expression phenotypes of many mye1in-re1ated genes follow the 
pro gram of myelin acquisition, with peak expression realized in the pre-weaning period 
(Stahl et al., 1990). To determine if the core enhancer sequences contained in the SA and 
135 bp fragments are sufficient to confer normal developmental expression 
programming, the quantitative phenotypes realized from the respective reporter genes 
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were followed throughout development. Both yield post-natal expression phenotypes that 
closely follow the endogenous MBP program; e.g., for SA, ~-galactosidase activity 
increases 6 fold from P2 through PlO followed by a decrease to one-fourth the peak level 
by 3 months of age (Fig. 4A). In a notable exception to normal programming, both 
sequences also drive low-Ievel expression in fetal nerves commencing at E13.5 dpc (data 
not shown), indicating that they lack elements essential for normal silencing of MBP 
transcription in Schwann cell precursors. 
High-Ievel expression of genes encoding the major myelin proteins requires that 
Schwann cells achieve and maintain axonal contact. Following axon transection, 
denervated Schwann cells in the distal nerve segment abruptly down-regulate numerous 
mye lin related genes such as MBP (LeBlanc and Poduslo, 1990). These are re-expressed, 
only when contact with in-growing axons is reestablished. To determine if the elements 
within the SA construct are sufficient to confer this injury/remyelination response, B-
galactosidase activity was evaluated in sciatic nerves regenerating in response to crush 
injury (Fig. 4B). Consistent with maintained axonal responsiveness, one week post-crush, 
B-galactosidase activity in the distal segment was reduced to one-third that expressed by 
uninjured contralateral nerves. When in-growing axons reestablish contact with Schwann 
cells in the distal segment (approximately two weeks post-crush), B-galactosidase levels 
increased, and by 4 weeks following in jury, when axon regeneration and remyelination 
are largely complete, expression levels were indistinguishable from control nerves. The 
same axon responsive expression program was revealed for the 135bp construct 
(histochemical analysis data not shown). Thus, both the 213 bp SA and the internaI 135bp 
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sequence are recognized by transcription factors that regulate MBP expreSSIOn III 
response to axonal signaIs. 
Mod4 contains distinct targeting and enhancing sub-domains 
As observed in both deve10ping and remyelinating preparations, Schwann cell 
targeting and responsiveness to axon signaIs are conferred by elements located within the 
core 135 bp sequence. To evaluate the potential role played by motifs located outside this 
domain, constructs differing in only small sets of additional motifs were analyzed for 
both qualitative and quantitative expression phenotypes. When compared to the 135 bp 
sequence, SA extends for 78 bps to inc1ude Ml7 to M22 and it drives expression at 3-fold 
greater levels (Fig. 5). In the 5' half of Mod4, where Ml to M9 are located, three 
constructs bearing contiguous MBP 5' flanking sequence, but terminating at different 
sites within or 5' of conserved Mod4 sequence, were analyzed. The sequence terminating 
at Sac II inc1udes motifs 10 to 22. The sequence terminating at -8.98 kb adds M5 through 
M9 and demonstrates a marked increase in expression levels in both young and mature 
mice. Similarly, the further addition of the sequence containing Ml through M4 (-9.4 kb) 
leads to an additional increase in expression levels but, only during the pre-weaning 
period of myelin formation. Thus, one or all of the MI-M4 motifs confer regulatory 
information and recognize factor/s that distinguish pre-weaning myelin elaboration from 
myelin maintenance in mature mice. 
Motifs in Mod4 sub domains are functional 
In an attempt to assign function to specifie elements we performed both band shi ft 
assays on motif specifie oligonuc1eotides and expression analysis with mutated 
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constructs. E1ectrophoretic mobility shift assays (EMSAs) were performed with probes 
representing conserved motifs in the SA sequence (Fig. 1). While such putative e1ements 
could act in diverse cell types, we searched for those that engage transcription factors 
expressed in Schwann cells by incubating the oligonucleotides with nuclear extracts 
prepared from PlO sciatic nerves. Consistent shifts were detected with 4 of the 8 probes 
(MU, M12-5', M14 and M16) (Fig. 6A) and as one indication of specificity, none were 
competed with oligonucleotides bearing 3-5bp substitutions in the motif cores. Thus, 
sorne motifs appear to engage factors expressed directly in Schwann cells while those 
that were not shifted may require cooperative binding not achievab1e on short 
oligonucleotides or engage factors expressed in different cell types. 
Motifs M14 and M16 are located in the 50 bp shown to be essential for Schwann 
cell targeting and M 18 and M20 are the most conserved sites present in the enhancing 
region of SA. We therefore searched for transcription factor binding sites located in the se 
conserved motifs. Using rVISTA software (Loots et al., 2002) several candidates with 
known relevance to Schwann cell biology and mye1ination were revealed. M14 and M18 
contain a Sox family binding site with potential to engage SoxlO. M16 contains sites for 
API and nuclear receptors RORA1 and ER (Desamaud et al., 2000; Miskimins and 
Miskimins, 2001) while M20 is a consensus binding site for Krox-20. 
To determine directly if M20 can bind Krox-20, we performed a competition 
experiment using a Krox control oligonucleotide shown to bind Krox-20 in our extracts 
(Chavrier et al., 1988; Forghani et al., 1999). Using sciatic nerve extracts, the M20 
oligonucleotide yie1ds a complex of 3 retarded bands and, as predicted, competition was 
observed with the Krox oligonucleotide as diminished signal for the 2 lower bands (Fig. 
15 
6B). As a further test of specificity, we expressed Krox-20 in bacteria and using total 
bacterial extract for M20 band shift, a single complex is formed that again was 
specifically competed with the Krox control oligonucleotide. We conclude that motif 
M20 is able to bind Krox-20 and therefore, that Krox-20 is a likely factor contributing to 
the activity of the enhancer within Schwann cells. In addition, M8, in the 5' half of 
Mod4, has a sequence compatible with Krox-20 binding activity and consistent with this 
function, it was also found to bind bacterially expressed Krox-20 (data not shown). Thus, 
one or more Mod4 motifs appear to function through interactions with Krox-20. 
To test the in vivo function conferred through individual motifs, constructs were 
derived in which mutations were introduced into the core of M14, M16, M18 and M20 
motifs (Fig. 1) and the consequences of such mutations on expression phenotypes were 
analyzed in mice. M14 and M16 mutations were each introduced into the 135 bp 
sequence and both affected expression; the M14 mutation silenced expression throughout 
post-natal development, while the M16 mutation reduced the expression level to 20% of 
control values in young animaIs and to 40% in adults (Fig. 6C). The reduction to zero or 
near zero expression observed with both mutant constructs reveals the essential 
cooperativity between factors bound to these motifs in conferring functionality to the 
I35bp subdomain. 
MI8 and M20 were mutated in the context of the longer SA sequence. Both 
mutations caused expression levels to decline with activity decreased to 50% of control 
values at most time points. An exception is the M 18 mutation at P4 where further 
reduction of activity approaching only 30% of the control value was observed. 
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As M 14 and M 18 share a common AACAA sequence (close to the Sox prote in 
consensus AACAA(T/A)RG for Sox9 in Transfac), and both motifs play an essential role 
in enhancer function, they may bind a particularly critical factor. To deterrnine if this 
factor could play a similar role in the regulation of other Schwann cell expressed genes, 
we searched for this motif in regulatory sequences from the Oct-6 SCE, Krox-20 MSE, 
PMP22 CRI, and a conserved region lying within 6 kb of sequence upstream of the PO 
gene (Table 1). AlI sequences are included in constructs shown previously to confer 
Schwann cell targeting. As shown in Table 1, the motif was present in multiple copies 
and conserved in all of these functional sequences. Sox 1 0, the candidate factor to bind 
M14, may therefore be a widely used component of the mechanism conferring expression 
in Schwann cells. 
Functional organization of Mod4 
The Mod4 organization emerging from this investigation shares numerous 
features with the regulatory mechanism controlling the endo-16 locus of sea urchin (Yuh 
et al., 1998). SpecificalIy, enhancer function is conferred through a small number of 
targeting elements operating in concert with large complexes of diverse factors that 
engage elements dedicated to modulating activity in response to physiological and 
developmental changes. When the different constructs investigated in the present study 
are aligned with the Mod 4 sequence conservation plot (Fig.7), the elements necessary for 
Schwann cell specificity are inc1uded in two peaks of high conservation corresponding to 
the 5' and 3' ends of the core 13 5 bp targeting sequence. In combination, they are 
essential for the basic Schwann cell targeting function while the two peaks of 
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conservation flanking this core confer various enhancing activities, sorne of which are 
restricted to specific developmental stages. 
DISCUSSION 
In this investigation, we show that M4 is composed of multiple conserved motifs, 
all of which contribute to the enhancer activity. We provide direct evidence that M 14 is 
critical to enhancer function while three other motifs make important quantitative 
contributions. M14 and M18 present a consensus binding site for SoxlO known to be 
present in Schwann cells (Kuhlbrodt et al., 1998). This transcription factor contains a 
high mobility group domain that bends DNA to facilitate the cooperative binding of 
transcriptional activators (Bust in, 1999; Ellwood et al., 2000) and is known to modulate 
expression of myelin genes such as PO in the PNS (Peirano et al., 2000) and MBP in the 
CNS (Wei et al., 2004). As suggested by our observations, it is also a critical factor in the 
formation of the MBP Schwann cell enhancer complex. While other M4 motifs were not 
found in the known sequences capable of driving Schwann cell expression in transgenic 
mice, the putative SoxlO binding site was found in multiple copies in all sequences and 
conserved in multiple species. These findings suggest an important, and perhaps central, 
role for Sox proteins in the regulation of Schwann cell expressed genes. 
In addition to the two putative SoxlO binding sites, M4 also contains 2 motifs that 
are able to bind Krox20. Such potential binding site redundancy has been observed in 
multiple enhancers leading to a general model in which enhancers can activate through 
factor binding at multiple sites (Berman et al., 2002). In the present investigation, such 
redundancy was anticipated and we focused our functional analysis on short, but still 
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functional sub-sequences to illuminate the critical elements conferring Schwann cell 
targeting. In the 135bp construct no obvious binding site for Krox20 was found 
suggesting that Krox-20 is not crucial but rather, as suggested for the periaxin gene, is 
used to amplify the activity of the enhancer (Parkinson et al., 2003). 
Using in vivo functional analysis, we demonstrate that M4 enhancer activity 
requires simultaneous contributions from elements located in both targeting and 
enhancing sub-domains. A more proximal MBP oligodendrocyte enhancer (Mod3) 
demonstrates a similar structure (Dionne et al., 2005) suggesting a general model of 
enhancer structure/function in which targeting, once established, achieves fine-tuning of 
expression phenotypes through the lateral recruitment of enhancing elements. 
Evolutionary diversification of such lateral elements could accommodate species-specific 
regulatory requirements and consistent with this hypothesis, divergence between 
mammalian and chicken M4 is more pronounced outside the targeting core. The extent to 
which this model is generally applicable will become evident only as the identity and 
location of functional elements in additional tissue specific enhancers become known. 
A recent study by Taveggia et al. (2004) used reporter constructs to characterize 
the MBP sequences important for expression in transfected Schwann cells and 
oligodendrocytes. In such in vitro preparations, the Mod4 sequence was found to confer 
robust enhancer activity in both Schwann cells and oligodendrocytes. Amongst the 
transgenic lines we have evaluated to date, no construct regulated by Mod4, or its 
derivatives, expresses in oligodendrocytes but we cannot exclude the possibility that 
Mod4 modulates the quantitative oligodendrocyte expression phenotypes controlled by 
other MBP modules. Altematively, as Taveggia et al. point out, glial cells cultured in the 
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absence of neurons may provide an unusual regulatory environment. Consistent with this 
potential in vitro limitation, we show here that Mod4 enhancer sub-domains are high1y 
responsive to Schwann cell-axon interactions. 
The experimental mutations introduced in this study led to dramatic effects on 
reporter gene expression supporting the view that natural mutations occurring in human 
regulatory sequences could cause, or significantly contribute to, gene deregulation and 
disease (Knight, 2005). If the organization of elements within MBP enhancers is typical, 
mutations in conserved motifs could variously silence, or significantly down regulate, 
transcription at one, or all, developmental stages. Further, maturation changes in the 
Schwann cell transcription factor repertoire, se en here for MBP regulation in juvenile and 
mature mice, could be a contributing factor in adult onset neuropathies. 
Finally, this investigation highlights the role in vivo functional analysis can play 
in the investigation ofmammalian regulatory mechanisms. Few techniques are capable of 
accurately revealing the expression phenotypes conferred by specific regulatory elements 
and these are most widely applied to non-vertebrate models or in vitro preparations. The 
results of this investigation further demonstrate that the controlled construct docking 
strategy introduced by Bronson et al. (1996) can be applied as an effective strategy to 
reveal high-resolution qualitative and quantitative in vivo expression phenotypes. By 
supporting comprehensive access to temporal, spatial and quantitative regulatory 
phenotypes, this robust in vivo approach emerges as an effective complement to both 
bioinformatics and molecular investigations on the structure and function of mammalian 
regulatory sequence. 
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Figure 1. Sequence alignment of Mod4 from four different species. 22 motifs of at least 6 
bp are conserved in mammals (highlighted and designated Ml to M22). Circles over the 
sequence indicate guanines footprinted by in vivo DNA analysis (open: protected; filled: 
hypersensitive). The Mod4 constructs are delineated by arrowheads along with their 
designations over the sequence. Oligonucleotides used in EMSA (Ml1 to M2l) are 
represented by lines under the sequence and mutations are indicated as white rectangles. 
M1 
mus CCAAGTATGTGGGTAGGCTGGGAGAAATACACTCCAGCGCTTG--CCTGAGGCTCTCCCGTTA----------- 61 
rat CCAAGTATGTGGGTAGGCCCCGAGGAATATAGTCCAGCTCTTG--CCTGAGGCCCTCTGGTTA----------- 61 
hum GGCCAGCGCATGGCCGCGCCTCGCCGACCCCGTCCCCACCCT----CCTGAGGCTCCCCTAGCACACGGCTGCCT 71 
chk GCTGATGGATCAGACAGGT-GATTTCATTCTTCCTCTGAGTACACAAAATGGTTTGTTACAAA----TGA 65 
-8.98 kb MBP > 
M2 M3 M4 
mus -TTGTGACCCC-TTTCTCGATGTGGGAGGGTCCCTGAGTGAGCTATTTAGAGT-ACATAAAAACTATATGTTCCG 133 
rat -TTGTGACCCCCTTTCTTGATGTGGGAGAGTCCCTGAGTGAGCTATTTAGAGT-ACAT~ATATGTTCTG 134 
hum CTCCTGTGGCCTCTTCCTGCCGTGGGAGGTGCCAGGGGTGAGCTATGTGGAGC-AAATAAAAACTATATGTTCTG 145 
chk TGCCCCAGCTCATTTCACTGTGGGATGATGACCCTTTGTAAGCTACTTAAGCTTAAACCAAACCTGTATGTTCTA 140 
M5 M6 M7 M6 0 M9 
mus AGCACACAAAAGAGGCATTC-GGTGTGTGGTGGGTGGGTTGACAAGATTCGTTTGTGG-AAGTCCTTG------A 200 
rat AACACACAAAAGAGGCATT--GGTGTGTGATGGGTGGGTTGACAAGGTTCGTTTGTGG-AAGCGCTTA------A 200 
hum GGCACACAAAGGAGCiCATT - -GGT<iTGAGAT6GGTGGCimiATGAGCCTCGTTTGTGGGAAAGTTTTC -- - -- -A 212 
chk GTAATAACAAAGGGACGTTTTTCTTTGAAACGGGTGGGTGGATAAAATTCTTTTAAGTTTGGTTTTTCTTTTAAA 215 
-6.9kb MBP> 
SA, 135,85> M10. M11 M12 
mus AGCTATCGCCGCGGGCAGCCTGGCCGGCAGCCACATGCCTTTCATAGATGCAGAATTTCTGTCATAGCAAGTCCA 275 
rat AGCCATCACCGCAGGCAGCCTGGCAGGCAGCCACATGCCTCTCATAGATGCA6AlTTTCTGTCATAGCAAGTCC- 274 
hum AGAAATCTCTGCGGGAAGCCT6GCAGGCAGCCAClTGCCTCTCATA6A1~CTGCCATCGCAAATCCA 287 
chk ATAAACCTTCTGCGGGTGTATGGAGAGCTGCCACATGCTTCTCATAGATTCCAAATTTCTGCCATAGCAAGTCCC 290 
--~~~==~~~==-----------
< 85 
107> M15 
M13 M14 _ M16 < 135 
mus --CAGGCTACACCATGGGCCTTTTTGTTTCCTGTGCCCTCCCAGGTGACCCCAAGCCCAGGCTGCCAGCGGCAGA 348 
rat - - -AGGCTACACCATGGGCCU li IGTTCCCTGTGCCCTCCCAGGrGACCCCGAGCCCAGGCTGCCAGTGGCAGA 346 
hum --CAGGCCACACCATGGCC~CCTTTGCCcrCCCTGGTGÀ((cCAAGCACAGCGCGCC-GTGACACA 359 
chk ACTGGTTTCAACCACAGGCTTTTTTGTTTTCTGTACTCTCTTTTGTAACCCTCAGCAAAGGGCGGCAATGCCAGA 365 
----~~ ~~-----
< 107 
M17 M16 M19 M20 M2l M22 < SA 
mus AGTATTCCATGAACAAGGAAGGTCCTCTCTAGCC-GGGCCCACACGCCCAGATTCCATAGCTCCTCTGCAGGCCT 422 
rat AGTATTCCATGAACAAGGAAGGTCCTCTCTAGCC-TGGCCCACACTTCCAGATTCCACAGCCCCTCTGCAGGCCT 420 
hum AGTATTCCACWCAAtiGAGCGTCCTCTTTGGCCCTGGCCCACACTTCCAAATTCCATGGT - -CTCTGCAGGGCT 432 
chk GTTGCTGGA-AAACAAGAGTGAGCGGCTGCAAGCCAGGCCTACACTGCTGCATTCCTCTAC--AATGGTAGGCCA 437 
-----I~ --c::J--
-------
Figure 2. In vivo footprinting experiments. DNA from pretreated sciatic nerves from PlO 
normal mice (WT) or adult Trembler-J mice (TR) were compared to purified DNA 
treated with dimethylsulfate (sequencing reaction lane C, T+C, A and G). Base 182 is 
protected while bases 225, 309 and 310 are hypersensitive. Footprinted bases are 
represented in Figure 1. 
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Figure 3. A, Distribution of motifs conserved in mammals and sequences analyzed as 
hspLacZ reporter constructs. Mod4 sequences that drive expression in peripheral nerves 
are indicated in blue. B, .B-galactosidase histochemistry of spinal cord and spinal root 
whole mount preparations. Human versus chicken Mod4 constructs at PlI and maturity. 
C, Whole mount preparations from mature mice bearing different Mod4 sub-domains. 
Note: central artery expression is observed with diverse reporter constructs docked at 
HPRT and is not related to Mod4 enhancer activity. 
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Figure 4. Reporter constructs are responsive to axonal signaIs. A, f3-galactosidase activity· 
in sciatic nerves peaks during early post-natal development. SA construct (black circles) 
and 135 construct (white circles). B, Expression of the SA construct following sciatic 
nerve injury and during remyelination of regenerating axons. f3-galactosidase activity in 
distal nerve segments (white) 1,2 and 4 weeks following nerve crush was compared to 
the uninjured contralateral nerve (black). Means +/- SD, N ~ 5. *** equals t-test result of 
P<O.OOI. 
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Figure 5. Developmental expression of constructs containing progressive deletions of 
mod4. A, SA and 135 bp hsp promoter constructs. B, Constructs regulated by -8.9, -8.98, 
or -9.4 kb of MBP 5' flanking sequences containing different complements of Mod4 
sequence. -8.9 kb terminates at the SacII site defining the 5' end of SA. -8.98 kb adds 
motifs M9 to M5 and -9.4 kb contains a1l22 Mod4 motifs. Means +/- SD. *** equals (-
test result of P<O.OO 1 , NS : not significant. 
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Figure 6. A, Interaction of motifs MIl, MI2-5', Ml4 and Ml6 detected by EMSA. 
Labeled oligonuc1eotides were incubated with PlO sciatic nerve extracts. Competition 
was performed with the oligonucleotides indicated on top of each lane. Note that two 
specific complexes are formed with oligonuc1eotide M16. B, M20 was used in EMSAs 
with sciatic nerve extracts (left panel) or bacterially expressed Krox-20 (right panel). 
Competitions were performed with M20, a Krox control oligonucleotide or M21. C, ~­
galactosidase activity in sciatic nerve samples from mice bearing control constructs (135 
and SA) or mutated constructs (135MI6mut and SAMl8mut and SAM20mut). The 
135Ml4mut construct has no activity and is not displayed. Means +/- SD, (-test results 
are indicated as P<O.05: *; P<O.OOI: ***. 
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Figure 7. VISTA plot of Mod4 sequence comparisons using a 20 bp window. Mouse and 
human (open) and mouse and chicken (filled) identities are displayed. Those sequences 
shown to be essential for Schwann cell targeting are shaded in blue while those 
conferring enhancing activity are white or shaded in grey (pre-weaning enhancing). The 
related Mod4 sequences included in reporter constructs are drawn below the plot. 
M14 M16 M18 M20 
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-9.4kb MBP .MBP 
~~~~ ................... .MBP 
-8.9 kb MBP 
-8.98kb MBP 
SA 
135 
Table 1. MBP Mod4 motif 14 is present in aIl sequences known to be capable of 
conferring Schwann ceIl expression to reporter constructs. In these different Schwann cell 
targeting sequences, the M14 motif, shown in bold, is conserved in multiple mammalian 
species (shown for mouse, rat, human, and dog). 
OCT-6 Mus TGACACAAACA CCACAGAAACAA 
SCEl Rat ATCCTCAG TGGGGGC 
(Mandem Hum TGACACAAACA CCACAGAAACAA 
akers et Dog ATCCTCAG TGGGGGC 
al., 2000) TGACACAAACA CCACAGGAACAA 
ACCCTCAG TGGGGGC 
AGGCACAAACA CCACAGGAACAA 
ACCCTTAG TGGGGGC 
* ********* *** ****** 
** ************ 
Krox-20 Mus CAGGAGTTTGTT AAATGTTAACAAT CAAATATTTGTT 
MSE Rat GTTTCGT TCAAAG CATTGCA 
(Ghislain Hum CAGAAGTTTGTT AAATGCTAACAAT CAAATATTTGTT 
et al., Dog GTTTCAT TCGAAG CATTGCA 
2002) CAGAAGTTTGTT AAATGTTAACAAT CAAATATTTGTT 
GTTTCAT CCAAAG CTTTGCA 
CAGAAGTTTGTT AAATGTTAACAAT CAAATATTTGTT 
GTTTCAT TCAAAG CTTTGCA 
*** ************* ***** ******* * *** ************* 
* ***** 
PMP22 Mus AGACCATAACA CCTAAGCAACAAC 
CRI Rat ATGAAGAG ACATTC 
(Maier et Hum AGACCATAACA CCTAAGCAACAAC 
al.,2003) Dog ATGAAGAG ACACTC 
CTAGTCTAACAA CCTAAGCAACAAT 
TGAAGAG GCATTT 
GATCTTCAACAA CCTAAGCAACAA 
GGAAAAG ACATTGG 
***** *** ** ************ 
PO Mus AAGTGGGAACA GCTGCTATTGTTC 
(Feltri et Rat AATCTCTT CCAAAT 
al., 1999) Hum AAGTGGGAACA TGGGCTATTGTTT 
Dog AAGCTCTT CCCAAA 
AAGTGGGAACA AGCGCTATTGTTT 
AATCTCTT CCCAGA 
AAGTGGGAACA AGTGCTATTGTTT 
AATGTCTT CCCAGA 
************* ********* ** * 
**** 
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CHAPTER4 
PREFACE 
The opportunity to use established transgenic lines as tools to expose the biology 
of myelinating glia was recognized early in the course of my graduate studies. An 
example is shown in this chapter on MBP-promoted transgene expression in heterozygote 
Trembler-J (TrJ/+) Schwann cells. While wild-type mice continue to express transgenes 
containing the Schwann cell enhancer 1 sequence into adulthood, TrJ /+ mice gradually 
shut down expression in the post-weaning period. Although this finding has not been 
fully reproduced in transgenic lines bearing HPRT docked constructs, a fundamental 
difference in the regulation of myelin prote in gene expression is suggested between the 
primary myelinating and remyelinating glial differentiation states. Developmental 
phenotypes are currently being systematically illuminated using numerous crosses 
between transgenic mice and mice bearing mutations in myelin related genes. 
MBP-LACZ TRANSGENE EXPRESSION IN JUVENILE AND ADULT 
TREMBLER-J MICE 
Hooman F.Farhadi, Reza Forghani, Alan C. Peterson 
Published in the Annals of the New York Academy of Sciences, 1999 
INTRODUCTION AND DISCUSSION 
2 
Myelin basic prote in (MBP) is expressed by both oligodendrocytes and Schwann 
cells. However, the regulatory elements in the MBP gene that drive expression in the two 
cell types are not the same. Transgenic mice bearing reporter constructs regulated by 
different lengths of MBP 5' flanking sequence have been derived to map their respective 
locations. The first few hundred base pairs of the promoter sufficient to target expression 
to oligodendrocytes, whereas an upstream enhancer element at approximately -10 kb is 
necessary for Schwann cell expression (Foran and Peterson, 1992; Goujet-Za1c et al., 
1993; Gow et al., 1992) (also, Forghani et al., manuscript submitted). Mice bearing 
constructs with MBP 5' flanking sequences extending up to and including the Schwann 
cell enhancer express B-galactosidase in both oligodendrocytes and Schwann cells. 
The Trembler-J (TrJ) mutation in the PMP22 gene (Suter et al., 1992) precludes 
the maintenance of normal myelin in the mature PNS. Although myelination initiates and 
progresses in these mice, signs of myelin breakdown are obvious as early as the second 
postnatal week (Henry et al., 1983).Throughout maturity, TrJ Schwann cells undergo 
3 
continuous rounds of abortive attempts at remyelination followed by division. In this 
investigation we asked whether the regulatory pathways that converge on the MBP 
Schwann cell enhancer are perturbed in TrJ mice. Expression of the MBP-lacZ reporter 
construct containing the Schwann cell enhancer was compared in juvenile and mature 
normal and TrJ/+ mice of the C57BL/6 strain. Whole mounts ofthe spinal cord and spinal 
roots were obtained from perfused animaIs and subjected to a histochemical assay for B-
galactosidase activity. 
Typical of all normal mice bearing this transgene, both oligodendrocytes and 
Schwann cells in TrJ /+ mice labeled in animaIs analyzed in the first few weeks of 
postnatal life. However, as these mice mature d, transgene expression appeared to be 
downregulated specifically in the PNS; by three months of age, B-galactosidase labeling 
could be detected only within the CNS (Fig. 1). 
Our observations suggest that Schwann cells in mature TrJ /+ mice are incapable of 
maintaining at least part of the program regulating mye lin protein gene expression that 
they successfullyaccess as juveniles. The basis of this unexpected difference could arise 
either (1) from changes at any level in the axon to Schwann cell signaling system, or (2) 
from intrinsic differences between juvenile and mature TrJ /+ Schwann cells due, for 
instance, to the differentiation state either cell is able to achieve. Furthermore, this finding 
could extend to differences between cells undergoing primary myelination and those 
remyelinating axons in a mature host. These issues are currently under investigation. 
Regardless of the level at which the change in transgene expression is orchestrated, 
our observations highlight a novel difference in the regulation of a normal myelin gene 
4 
during the juvenile phase when the elaboration of mye lin normally occurs and that which 
is attempted in TrJ /+ mice during remyelination in mature animaIs. The possibility that 
such maturation-related changes in gene regulation could contribute to the pathogenesis 
of CMT or additional peripheral neuropathies deserves further investigation. 
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CHAPTER5 
GENERAL DISCUSSION 
PREFACE 
This chapter provides a general discussion of the investigations described in chapters 
two, three, and four, as well as a discussion of future directions and implications for glial 
biology and functional genomics research. By necessity, there is sorne redundancy 
between the content of this chapter and the individual discussions in previous chapters. 
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Axons exhibit an intimate anatomic and functional relationship with central and 
peripheral myelinating glia throughout development and maturity. Reciprocal axo-glial 
interplay occurs in a series of stages yielding phenotypically mature myelinated fibres. 
An important developmental mile stone in the terminal differentiation of oligodendrocytes 
and Schwann cells is the formation of compact myelin. This is achieved, in part, through 
the coordinate up-regulation of genes encoding myelin structural proteins (Kidd et al., 
1990; LeBlanc and Poduslo, 1990; McPhilemy et al., 1990). 
The expression of reporter constructs in transgenic mlce has been applied 
intensely to identify sequences from myelin prote in genes that contain oligodendrocyte or 
Schwann cell specific targeting elements (Foran and Peterson, 1992; Gow et al., 1992; 
Gravel et al., 1998; Maier et al., 2002; Messing et al., 1992; Wight et al., 1993; Wrabetz 
et al., 1998). However, two general obstacles have prevented significant progress using 
this approach. First, regulatory sequences have been found to constitute only a small 
fraction of the non-co ding portion of the mammalian genome. AIso, the effects of 
elements that serve to modulate expression levels, rather than cell type specificity, are 
generally detectable only at low resolution in transgenic mice where constructs have 
inserted at random sites in the genome in variable numbers and configuration. 
This thesis examines the transcriptional regulation of one representative myelin 
protein gene, Myelin Basic Protein (MBP). To overcome the above limitations, l used a 
two-pronged approach combining interspecies non-coding sequence comparisons with 
targeted de li very of single-copy constructs at the ubiquitously expressed hypoxanthine-
guanine phosphoribosyltransferase (hprt) locus. 
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Comparative human-mouse genomic analysis reveals four highly conserved modules 
Comparison of orthologous sequences has emerged as a powerful tool in genome 
analysis. Such 'phylogenetic footprinting' (Pennacchio and Rubin, 2001) provides 
complementary data to computational, consensus sequence based predictions, as 
sequence conservation through evolution highlights segments in non-co ding reglOns 
likely to play a functional role in the regulation of gene transcription. 
As functional sequences are under selective pressure to be retained over moderate 
periods of evolution, the first challenge in phylogenetic footprinting is the choice of 
species to compare. An adequate balance between biological similarity and evolutionary 
distance optimizes the chances of identifying conserved sequences that appear to be 
evolving under evolutionary constraints in a background that has randomly diverged due 
to genetic drift. 
In recent years, the availability of sequence from numerous species has allowed 
multiple interspecies comparisons to aid in calibrating the ideal evolutionary distance 
required for the optimal identification of functionally conserved sequences (Gottgens et 
al., 2002; Pennacchio and Rubin, 2001). The evolutionary distance between humans and 
mice places these species at strategic positions for the identification of shared 
functionally conserved sequences. Several studies have suggested that only a small 
portion (17-20%) of non-coding regions are conserved on average at this evolutionary 
distance (~80 million years) (Shabalina et al., 2001; Wasserman et al., 2000). 
Due to a paucity of functional investigations, the significance of aIl such 
evolutionarily conserved non-coding sequences is yet to be fully determined. However, 
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the possibility that they play a gene regulatory role is being studied for an increasing 
number of loci. Reassuringly, functional sequences at several loci have been identified 
solely through the use of human-mouse genomic comparisons, further validating this 
assumption (Gottgens et al., 2000; Kappen and Yaworsky, 2003; Loots et al., 2000; 
Pennacchio et al., 2001). 
Furthermore, similarity appears to be punctuated, with distinguishable segments 
of high similarity flanked by regions of apparently random sequence (roughly 33% 
nucleotide identity has been observed between random genomic sequences, with wide 
variations dependent upon the applied alignment algorithm, settings, and sequence 
characteristics (Duret and Bucher, 1997). This compartmentalized pattern of similarity is 
consistent with an emerging model in which multiple transcription factors bind in dense 
clusters termed regulatory modules (Arnone and Davidson, 1997); a circumstance which 
also suggests that contiguous blocks of sequence are required for transcriptional 
regulation. 
Previous investigations, us mg randomly integrated reporter constructs in 
transgenic mlce containing 1.9, 3.1, 5.8, and 8.9 kb of MBP 5' flanking sequence 
suggested that expression is primarily conferred through regulatory elements located 
within the 5' flanking region (Foran and Peterson, 1992; Forghani et al., 2001; Gow et 
al., 1992). These investigations also demonstrated that expression in oligodendrocytes 
and Schwann cells is mediated through different non-coding regions. 
In an attempt to expand these observations and reveal the full complement of 
MBP regulatory elements, we decided to search for segments of preferential conservation 
in the MBP 5' flanking region by undertaking a comprehensive long-range comparison of 
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human and mouse genomic sequences. Four short, widely spaced, conserved modules 
were identified. Interestingly, modules 1, 2 and 4 overlapped (at least in part) with 
sequences previously implicated in oligodendrocyte or Schwann cell targeting function 
(Foran and Peterson, 1992; Forghani et al., 2001; Gow et al., 1992). However, module 3 
represented a novel potential regulatory domain illuminated directly through comparative 
sequence analysis. 
Identification of a complex integrated network of evolutionarily conserved MBP 
regulatory modules 
Although phylogenetic footprints have the potential to significantly focus future 
investigations, genes such as MEP, which are regulated through complex axo-glial 
interactions, present a further challenge to experimental design and interpretation. This is 
in part due to the lack of an in vitro model that completely and robustly recapitulates the 
phenotype of myelinated fibers. 
Consequently, 1 adopted an in vivo functional strategy with the potential to 
support high-resolution structure/function analyses. Specifically, (Bronson et al., 1996) 
introduced a strategy of transgenesis in which a single-copy construct is inserted in a 
controlled manner into a predetermined site in the 5' flanking sequence of the hprt locus. 
Thus, full control over the transgene genotype was provided and the opportunity to make 
direct and meaningful comparisons between the expression phenotypes of different 
constructs became available. As a first step, 1 set out to determine whether the chosen 
docking site is both permissive and neutral for MBP regulatory sequences. Representative 
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constructs, previously characterized in numerous independently derived random insertion 
transgenic lines, displayed predicted spatiotemporal expression patterns. Furthermore, a 
sensitive enhancer trap construct showed no expression in myelinating glia, thus 
suggesting that cell-specific enhancers for MBP were not significantly deregulated by 
enhancers associated with the ubiquitously expressed hprt locus itself. On the basis of the 
above results, l concluded that direct inter-construct regulatory pro gram comparisons 
could be made reliably. 
Constructs were then designed to interrogate the individual and combined 
regulatory roles conferred through the MBP modules. Throughout this analysis, hprt 
targeting allowed the use of interconstruct comparisons to assign precise spatiotemporal 
and quantitative phenotypes. A simple additive relationship amongst the regulatory 
sequences likely accounts for most of the quantitative interconstruct differences. 
However, summation of the expression levels derived from constructs regulated by 
individual modular sequences yields a value approximately one-half that observed for a 
construct regulated by -9.4 kb of contiguous MBP sequence. This observation may be 
related to either the exclusion of functionally relevant sequence from the predefined 
modules or to the influence of intermodular combinatorial relationships. It appears likely 
that, at least in part, the former explanation may be involved, especially when one 
considers the marked difference in expression observed for M3 alone as compared to M3 
in the context of 2.3 kb of surrounding sequence. 
As a second step in the analysis of the MBP regulatory pro gram, l initiated the 
dissection of the modules themselves, first searching for the minimal sequence required 
to confer enhancer function and then to interrogate the contributions of individual motifs 
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with similarity to known transcription factor binding sites. Notably, M3, which appears 
necessary for mediating high-Ievel expression to mature and newly myelinating adult 
oligodendrocytes, contains three high-affinity consensus sites for the homeodomain 
transcription factor Nkx6.2/Gtx (Awatramani et al., 1997). Although mutation of two of 
these core domains did not eliminate oligodendrocyte targeting, a significant reduction 
(~35%) was achieved in oligodendrocyte expression levels. CUITent investigations 
underway are examining the regulatory function of M3 subdomains and other putative 
transcription factor binding sites (Dionne et al., 2005). 
In a gratifying extension of the earlier studies on MBP modular structure, we have 
now shown that similar combinatorial relationships exist at the level of elements within 
an individual module (Denarier et al., submitted). While in the M4 enhancer core, seven 
contiguous motifs cooperate to confer Schwann cell specificity, different combinations of 
flanking motifs engage, at different stages of Schwann cell maturation, to modulate 
expression levels. Mutation of a Krox-20 binding site reduces the level of reporter 
expression while mutation of a potential Sox element abrogates expression. The potential 
Sox motif also was found conserved in other Schwann cell enhancers suggesting that it 
contributes widely to regulatory function. 
Taken together, these observations are of specifie interest to myelin formation and 
disease. They provide the basis for a complex model in which the expression of MBP in 
myelinating glia is finely regulated throughout development, maturity, and following 
injury, through the integrated output of a network of regulatory sequences. Recently, 
further confirmation was provided for this combinatorial cell state dependent control of 
MBP expression. Using an oligodendrocyte precursor Oli-neu cell line (Gokhan et al., 
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2005), transient co-transfection assays were undertaken with a luciferase reporter gene 
driven by -1.3 kb of MBP 5' flanking sequence. Transcription factors assayed included 
Olig 1, Olig2, Mash 1, and Sox 1 O. Analysis of reporter gene levels revealed transcription 
factor expression profile and developmental stage dependent regulation, pointing to a 
combinatorial transcription factor interplay in the regulation of MBP expression. 
Finally, from the vantage point of our CUITent understanding, it seems probable 
that genes such as MBP are not regulated through interactions between private factors 
and elements but, rather, by factors and elements that are widely shared amongst the 
genes contributing to the myelin phenotype (Denarier et al., submitted). Thus, rather than 
magnifying a progressively more limited segment of glial biology, the identification of 
the specifie regulatory elements and transcription factors that engage to regulate MBP 
appear to be opening a wide window onto the molecules and mechanisms controlling the 
overall myelination program. 
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